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Preface 
This document describes the statistical analyses planned as part of the scientific project entitled “Pesticide 
Exposure, Asthma and Diabetes in Uganda” (PEXADU). The document is based partly on the project protocol 
that was approved by the institutional review board at Makerere University School of Public Health (Kampala, 
Uganda) on July 2, 2018. The document also contains information from a presentation of preliminary results1 
made at the 2019 EPICOH (Epidemiology in Occupational Health) conference. The abstract for the latter is 
freely available from https://oem.bmj.com/content/76/Suppl_1/A3.1  
1 Abstract 
BACKGROUND 
Insecticides are important both to control agriculture and for the fight against vector-borne diseases such as 
malaria. Previous studies show that relatively low exposure to organochlorine insecticides is associated with 
diabetes mellitus, but less is known for other more widely used classes of insecticides such as 
organophosphates and other insecticides. Other studies suggest an association between insecticide exposure 
and lung function impairment, but the publications are few and hampered by weak study designs and 
insufficient confounder control. 
AIMS 
1) Investigate the possible association between insecticide exposure, diabetes and lung function 
impairment. 
2) Assess whether the effects are acute or chronic, reversible or irreversible. 
3) Establish exposure-response relationships between specific insecticides and health outcomes for risk 
assessment and management. 
METHODS AND MATERIALS 
Repeated cross-sectional study among two groups of small-scale farmers from the Wakiso District of Uganda: 
conventional farmers and semi-organic farmers. The main outcome of interest are temporal changes in blood 
glucose levels (determined fasting plasma glucose and glycosylated hemoglobin A) and objective lung function 
parameters.  Insecticide exposure is determined by passive sampling using silicone bracelets, measurement of 
blood acetylcholine esterase and subjective exposure information. 
PERSPECTIVES 
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If exposure to insecticides increase the risk of diabetes or lung function impairment, it will have to be taken 
into account when planning public health interventions using insecticides against vector-borne diseases and 
when using insecticides in agriculture. 
2 Acronyms and abbreviations 
• ACh = acetylcholine 
• AChE = acetylcholine esterase 
• ATS = American Thoracic Society 
• AU = Aarhus University, Aarhus, Denmark 
• DM =  diabetes mellitus 
• DM1 = diabetes mellitus type 1 
• DM2 = diabetes mellitus type 2 
• FEV1 = forced expiratory volume in 1 second 
• FEV6 = forced expiratory volume in 6 seconds 
• FEV1/FVC = FEV1 divided by FVC 
• FPG = fasting plasma glucose 
• FVC = forced vital capacity 
• HbA1c = glycosylated hemoglobin A 
• MU = Makerere University, Kampala 
• NRCWE = National Research Center for the Working Environment, Copenhagen, Denmark 
• ODK = Open Data Kit (https://opendatakit.org/) 
• OP =  organophosphates (refers to organophosphate insecticides only) 
• OUH = Odense University Hospital, Odense, Denmark 
• PEXADU  = “Pesticide Exposure, Asthma and Diabetes in Uganda” (project title) 
• RCM = Random Coefficient Model 
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• UNACOH = Uganda National Association of Community and Occupational Health 
3 Definitions 
• Acetylcholine 
Neurotransmitter substance. The main neurotransmitter of the parasympathetic nervous system. 
• Acetylcholine esterase 
Enzyme that catalyzes the breakdown of acetylcholine. Important for the normal function of nerves 
that use acetylcholine as a transmitter substance. 
• Asthma 
Chronic inflammatory airways disease characterized by hyper-reactive airways and intermittent 
bronchoconstriction, mucus hypersecretion and edema of the airway mucosa. 
• Bronchoconstriction 
Narrowing of the airways. 
• Bronchodilator 
Medication that cause airway smooth muscle cells to relax so that the airways open up more. 
• Chronic bronchitis 
Chronic inflammation in the bronchi (lower airways). Clinically defined as coughing and bringing up 
phlegm for most days for at least three months two years in a row. 
• Chronic obstructive lung disease 
Chronic pulmonary disease with varying components of emphysema and chronic bronchitis. Often 
known as “smoker's lung”, but other influences than smoking can also lead to the disease. 
• Diabetes 
Common term for diabetes mellitus. Technically, the word “diabetes” can also mean “diabetes 
insipidus”, but that is an entirely different disease that will not be discussed further in this protocol. 
• Diabetes mellitus 
A heterogeneous group of diseases characterized by varying degrees of hyperglycemia, insulin 
resistance and decreased insulin production. The main types are diabetes mellitus type 1 
(characterized by autoimmune destruction of the insulin-producing beta-cells of the pancreas) and 
diabetes mellitus type 2 (characterized primarily by insulin resistance). 
• Dyspnea 
Shortness of breath. 
• Emphysema 
Destruction of septa between the alveoli, leading to 
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o Decreased gas exchange in the lungs 
o Decreased elasticity of the lung tissue (and thus, dynamic airway collapse during exhalation) 
• Forced expiratory volume in 1 second 
The amount of air that is exhaled in the first second of a forced exhalation following a maximal 
inhalation. Measured by spirometry. 
• Forced vital capacity 
The total amount of air that can be exhaled following a maximal inhalation. Measured by spirometry. 
• FEV1/FVC ratio 
Forced expiratory volume in 1 second divided by forced vital capacity. A measure of airway 
obstruction. 
• Glycosylated hemoglobin A 
Hemoglobin A (the main oxygen-transporting molecule in the blood) that has non-enzymatically 
reacted with glucose. The speed of this reaction depends on the glucose concentration in the blood, 
so glycosylated hemoglobin A can be used as a measure of mean blood glucose level during the last 6-
8 weeks. 
• Herbicide 
Pesticide targeted against plants. 
• Hyperglycemia 
Increased blood glucose level. 
• Insecticide 
A pesticide targeted against insects. 
• Mucus hypersecretion 
Abnormally high production of mucus in the airways. 
• Pesticide 
A chemical compound used to kill organisms considered unwanted by humans. In the context of this 
protocol, the term only considers synthetic compounds and not natural compounds such as plant 
extracts, or insect-killing bacteria. 
• Spirometry 
Clinical examination of a person's ability to exhale air (amount and velocity). Commonly referred to as 
"lung function testing", but does not test the ability of the lungs to perform gas exchange. 
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5 Background 
Use of pesticides is important for both modern agriculture and control of vector-borne diseases such as 
malaria. However, scientific studies indicate that chronic exposure to pesticides can lead to health damage – 
even at low levels without any acute symptoms. Among other things, associations with both diabetes mellitus, 
respiratory symptoms, and decreased lung function are suspected.  
A systematic review has indicated an association between exposure to insecticides and the risk of diabetes 
mellitus,2 a serious disease affecting an estimated 2.8 percent of the population of Uganda.3 The majority of 
the studies included in the systematic review only considered organochlorine insecticides such as DDT 
(dichloro-diphenyl-trichloroethane)2. Less is known about more widely used groups of insecticides such as 
organophosphates. However, there are indications that also organophosphates can cause diabetes mellitus. A 
study from a rural area in Iran found significant higher fasting blood glucose (FBG) levels among 
organophosphate-exposed farmers than among matched non-exposed controls (mean FBG 84.90 vs. 78.31 
mg/dL, respectively).4 Furthermore, a recent publication indicated that organophosphate exposure among 
Indian farmers changed the gut microbiome, causing increased production of short-chain fatty acids in the 
intestines and thus, increased risk of diabetes mellitus.5  
Chronic obstructive lung disease is a common disease affecting 16.2% of men and women in rural Uganda.6 In 
recent years, it has been suggested that low-dose pesticide exposure is linked to respiratory symptoms and 
decreased lung function. A 2014 review concluded that exposure to pesticides may be associated with airway 
obstruction, and that the evidence was stronger for asthma than for chronic obstructive pulmonary disease.7 
However, the authors found that many of the studies had weak designs and did not adequately deal with 
confounders.7 A recently published study from Ethiopia demonstrated that the FEV1 (forced expiratory volume 
in 1 second) was significantly lower among farmers directly exposed to pesticides, and they found an exposure-
response relationship with higher-exposed persons performing worse.8 An association between 
organophosphate and carbamate insecticides and respiratory symptoms, asthma and chronic obstructive 
pulmonary disease is biologically plausible. The primary effect of organophosphates is  inhibition of the 
enzyme acetylcholine esterase, the enzyme responsible for degrading acetylcholine.9 Acetylcholine is the 
neurotransmitter of the parasympathetic nervous system (PNS). Increased activity in the PNS leads to 
bronchoconstriction and increased mucus production - both well-known signs of acute organophosphate 
intoxication.10 
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6 Hypotheses 
1.   Exposure to organophosphates and other insecticides increases the blood sugar level. 
2.   Exposure to organophosphates and other insecticides increases the risk of diabetes. 
3.   Exposure to organophosphates and other insecticides leads to bronchoconstriction. 
4.   The effects described in hypothesis 1-3 follow a positive exposure-response relationship. 
7 Objectives 
7.1 General objective 
To examine the temporal relationship between exposure to insecticides and changes in glycemic status and 
lung function among a group of occupationally exposed farmers. 
7.2 Specific objectives 
To statistically describe changes in the following primary parameters in relation to a two-month spraying 
season: 
• Fasting plasma glucose, 
• Glycosylated hemoglobin (HbA1c), 
• Lung function measurements (FEV1, FVC and FEV1/FVC), 
and to model these changes as a function of each participant’s exposure level. 
8 Data collection methodology 
8.1 Setting 
Data was collected from a group of 364 small-scale farmers from the Wakiso District in central Uganda. The 
farmers were recruited from two farmer’s organizations – one organization for conventional farmers (with 
assumed high level of exposure to pesticides) and one organization of farmers working towards organic 
certification (with an assumed lower level of pesticide exposure). Participants were recruited in July 2018 by 
visiting individual farmer’s groups associated with each of the two larger farmer’s organizations. Participants 
were interviewed and examined at an examination center that was set up for this project. 
8.2 Study design 
We carried out three repeated cross-sectional studies in the same study population: 
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• Phase 1: Early September – early October 2018 
• Phase 2: Mid-November – early December 2018 
• Phase 3: Early January – early February 2019 
The timing of the study was chosen because we expected farmers to use the most pesticides in October-
November, and smaller amounts before and after. This expectation was based on knowledge about the timing 
of the agricultural seasons in the Wakiso District (personal communication, Aggrey Atuhaire, UNACOH). 
8.2.1 Criteria for inclusion and exclusion 
8.2.1.1 High-exposed persons 
• Inclusion criteria: Members of the selected farmers’ groups from the conventional farmers’ organization. 
Both females and males above the age of 18 years will be recruited. 
• Exclusion criteria: 
o Persons who refuse to sign the informed consent form. 
o Women who report pregnancy. 
o Lung function testing will not be performed for participants who report any of the following: 
 Myocardial infarction in the last 3 months. 
 Suffering from angina pectoris. 
 Suffering from hemoptysis 
 Any kind of surgery in the last 3 months 
 Aortic aneurism 
 History of pulmonary embolism 
8.2.1.2 Low-exposed persons 
• Inclusion criteria: Members of the selected farmers’ groups from the semi-organic farmers’ group. Both 
females and males above the age of 18 years were recruited. 
• Exclusion criteria: Same criteria as for exposed persons (see above). 
8.3 Data collection 
8.3.1 Questionnaire-based structured interview 
Insecticide exposure was determined primarily by interviewer-administrated questionnaires. We collected 
data on the duration of working with agricultural pesticides, the intensity of insecticide exposure during work, 
the personal protective equipment and the types of insecticides used. Information on known risk factors for 
diabetes and pulmonary disease were collected using an adapted version of standardized STEPS instrument11 
(developed by the WHO), supplemented with questions from other standardized questionnaires. The 
questionnaire included questions on diet, physical activity level and other possible confounders. 
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8.3.2 Biological samples 
At each examination, one or two finger-prick capillary blood samples and one 4ml venous blood sample were 
taken for point-of-care biochemical analysis. In addition, a random sample of participants gave spot urine 
samples that were stored for later analysis: 
Sample type Parameter measured Purpose Eligible participants 
Measurement 
device 
Venous full blood 
(anticoagulant: 
K2-EDTA) 
HbA1c Primary measure of glycemic regulation Everyone 
HemoCue Hba1c 
501 
Capillary full 
blood 
Fasting plasma 
glucose 
Secondary measure 
of glycemic 
regulation 
Those who came 
fasting in the 
morning 
HemoCue Glucose 
201 RT 
Capillary full 
blood 
AChE 
Hemoglobin 
concentration 
AChE normalized 
by hemoglobin 
concentration 
Biomarker of 
exposure to 
organophosphate 
and carbamate 
insecticides 
Everyone 
Test-mate ChE 
Cholinesterase 
Test System 
(Model 400) 
Spot urine Pesticide metabolites 
Objective measure 
of recent pesticide 
exposure 
Random sub-sample 
of participants 
(selected using 
pseudo-random 
number generator). 
50% of conventional 
farmers, 20% semi-
organic farmers. 
Not yet measured. 
Planned to be 
analyzed using LC-
MS. 
 
Glycosylated hemoglobin A (HbA1c) is a measure of the average blood glucose levels for the last 6-8 weeks12.  
8.3.3 Silicone bracelets 
All participants were asked to wear a silicone bracelet from phase 1 to phase 2. A random subsample of 
approximately 100 persons were also asked to wear a silicone bracelet from phase 2 to phase 3. The latter 
group was randomly selected among participants eligible to give urine samples – see “8.3.2 Biological 
samples”. The silicone bracelets passively absorb insecticides at a rate relative to the exposure levels.13 14 
In phase 2 and 3, we collected the bracelets, packed them in diffusion-proof bags and stored them at -20 
degrees Celsius. The bracelets will be shipped to Denmark for analysis of insecticide residues using liquid 
chromatography – mass spectrometry (LC-MS). 
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8.3.4 Lung function testing 
At each examination round, eligible participants performed spirometry without reversibility testing using a 
handheld spirometer and according to guidelines from the American Thoracic Society.15  Reversibility testing 
was not carried out, as we did not have ethical clearance for the administration of bronchodilator medicine. 
During each testing session, each participant blew a minimum of five and a maximum of nine times. 
Spirometry was carried out using a diagnostic-quality spirometer (MicroMedical MicroDL). In addition, 
participants eligible for spirometry in phase 1 were also tested using a mini-spirometer (Vitalograph copd-6). 
The order of testing (MicroDL or copd-6 first) was determined using a pseudo-random number generator. 
Participants always blew into the copd-6 three times. The purpose of including the copd-6 device in the project 
was to evaluate is precision and accuracy, and hence to judge whether this cheaper device can reliably be used 
for lung function testing in future studies on environmental and occupational health. 
8.3.5 Anthropometry 
Height and weight were measured to determine BMI (body mass index). We also measured participants’ hip 
and waist circumferences for calculation of the hip-to waist ratio, and measured participants’ blood pressure 
and pulse rate. 
8.3.6 Data management 
In the field, the majority of the collected data was collected in digital format using ODK (Open Data Kit) 
software. Only minor amounts of data (participant registration sheets, information from filled-out informed 
consent forms and registration sheets with biochemical results) were collected in paper form, and later 
digitized in duplicate using ODK. 
Data will be managed and analyzed using the Stata 15 statistical software package (StataCorp LLC, College 
Station, Texas). 
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9 General considerations for statistical analyses 
9.1 Overview of analyses 
The planned analyses are presented below. Analyses are placed in four groups, corresponding to the subjects 
of the planned papers from the PEXADU project: 
• 10 Analysis plan for organophosphate exposure  
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• Analysis plan for glycemic regulation 
• 12 Analysis plan for lung function tests 
• 13 Analysis plan for validation of Vitalograph copd-6 
9.2 Level of significance 
p-values ≤ 0.05 will be considered significant. 
A relatively high number of statistical tests will be carried out because of the many independent variables we 
want to examine - e.g. HbA1c (continuous), FPG (continuous), diabetes (yes/no), FEV1 z-score (continuous), FVC 
z-score (continuous) and FEV1/FVC z-score (continuous). The number of tests means that there is a risk of mass 
significance, i.e. finding statistically significant results where no true differences exist. By definition, this will 
happen in 5% (= the level of significance) of all tests. While we will not try to account formally for this (e.g. by 
Bonferroni correction16), it will be kept in mind when interpreting results. 
9.3 Interdependence of data 
Because of the way participants were recruited for the PEXADU project, some participants were relatives. 
Before any more advanced analyses are carried out, we will tabulate the number of participants who stated 
that they were related to another participant. Depending on the result, we may decide that the 
interdependence between observations is negligible, or we may decide that it is sufficiently large to warrant 
consideration in the statistical analyses (e.g., by including family as a random effect in mixed effect models). 
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10 Analysis plan for organophosphate exposure 
10.1 Purpose and introduction 
Most of the available information on pesticide exposure in the PEXADU project is questionnaire-based. 
Measurements of red blood cell acetylcholine esterase (AChE) are available for all persons in all phases, but 
express exposure to only organophosphate and carbamate insecticides in the last approximately three months 
(see details in section 1.1.1). In order to assess health effects of any other pesticides, as well as effects of long-
term exposure to organophosphate and carbamate insecticides, we will create and validate a pesticide-
exposure score with information on specific pesticide compounds. Our primary exposure score will be based 
on a deterministic model, but we will also develop a statistical model in order to get an empirically based 
exposure score. 
At the time of writing, the only biomarker of pesticide exposure available from the PEXADU project is AChE. As 
preliminary analyses of the data has shown that very few persons in the study had used carbamates, and none 
had done so within the last week before the interview (data not shown), we will only be able to validate the 
exposure scores for organophosphate insecticides. We are still working on getting the necessary permits to 
export the urine samples and silicone bracelets from Uganda to Denmark for analysis so that we can also 
validate scores for other classes of pesticides. 
10.2 Statistical procedures 
The derivation and validation of the pesticide exposure score will be based on self-reported exposure to 
organophosphates before each interview (phases 1/2/3) and validated against AChE measurements. To derive 
the best possible exposure score, we will create and compare the performance of two statistical models: A 
deterministic model and an empirical model. 
10.3 Descriptive statistics 
Before the analyses are carried out, we will draw a table of demographics, stratified by organization 
membership (outlined in   
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Table 1). For the persons who reported ever having mixed or applied pesticides in the baseline interview, we 
will draw a table specifying the frequency of use of all listed types of PPE, and hygienic practices (outlined in 
Table 2). 
  
Analysis protocol: Pesticide Exposure, Asthma and Diabetes in Uganda (PEXADU) 
 
Page 17 of 78 
TABLE 1: DEMOGRAPHICS 
Characteristic All participants Conventional farmer’s group Semi-organic farmer’s group 
Total n    
Sex    
   Male, n (%)    
   Female, n (%)    
Age in years: 
Median, IQR 
   
Educational level (years 
of full-time schooling): 
Median, IQR) 
   
Alcohol consumption in 
the last week (unit): 
Median, IQR 
   
Farming as main 
occupation: n (%) 
   
Ever mixed or applied 
pesticides, n (%) 
   
Mixed or applied 
pesticides in week prior 
to interview 
   
  Phase 1, n (%)    
  Phase 2, n (%)    
  Phase 3, n (%)    
Number of hours of farm work (excluding work with pesticides) in the last week 
  Phase 1: Median, IQR    
  Phase 2: Median, IQR    
  Phase 3: Median, IQR    
Number of hours of farm work (excluding work with pesticides) in the last week, limited to farms where 
pesticides are used 
  Phase 1: Median, IQR    
  Phase 2: Median, IQR    
  Phase 3: Median, IQR    
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TABLE 2: DESCRIPTIVE STATISTICS FOR PPE USE AND HYGIENIC PRACTICES 
 All participants Conventional 
farmer’s group 
Semi-organic 
farmer’s group 
Total n    
PPE type Frequency of use, n (%) 
Dust mask All the time (100%)    
Most of the time (75%)    
Often (50%)    
Rarely (25%)    
Never (0%)    
(…) 
Cap All the time (100%)    
Most of the time (75%)    
Often (50%)    
Rarely (25%)    
Never (0%)    
Time of 
showering 
Immediately or within 
one hour, n (%) 
   
A few hours later, n (%)    
Many hours later, n (%)    
Next day, n (%)    
Time of 
changing 
clothes 
Immediately or within 
one hour, n (%) 
   
A few hours later, n (%)    
Many hours later, n (%)    
Next day, n (%)    
 
10.4 Description of the deterministic exposure model 
The deterministic exposure model will take into account the amount of organophosphate insecticides used, 
the timing of exposure, the potency of individual compounds, PPE use and hygienic measures. These factors 
are described in details below. 
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10.4.1 Weighting factor for time since exposure 
While carbamate insecticides reversibly inhibit AChE,17 the inhibition caused by organophosphate insecticides can be irreversible.17 This means that even 
though organophosphates are not biologically persistent in the human body, the inhibition caused by organophosphate insecticide exposure can persist for 
a considerable amount of time after the exposure happened.18  
A study among workers occupationally exposed to the organophosphate insecticide dichlorvos showed that RBC AChE did not revert to baseline until after 
approximately 82 days after the exposure ended, and the increase in RBC AChE was a linear (as opposed to exponential) function of time.18 In our analyses of 
subjective exposure information vs. AChE, we have to take into account this duration of AChE inhibition after exposure. 
The interval between examinations of each participant in our study was approximately 2 months. At each examination, the participants were asked about 
the pesticides that they had used most in the last week before the examination. In phases 2 and 3, they were additionally asked about the pesticides they 
had used most since the last examination, but not in the last week. In phases 1, we instead asked them about the pesticides they had used most since they 
started using pesticides, but not in the last week. I.e., in phase 1 we do not know the timing of the exposure that happened more than one week before the 
examination. An overview is provided in Figure 1. 
FIGURE 1: OVERVIEW OF TIMING OF EXAMINATIONS AND TIMING OF EXPOSURE INFORMATION 
 
OP = Organophosphate insecticides. The durations of the time windows are not to scale.
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As outlined in Figure 1, we expect AChE measurements in both of the phases 1 and 2 to be influenced by 
exposure in the time preceding the phase 1 examination by more than one week (i.e., in a time interval where 
we do not know the timing of exposure). This means that it will be difficult to estimate how much participants 
have been exposed within the time window where the exposure could influence AChE in phases 1 and 2. Only 
in phase 3 do we have a good idea of the timing of all organophosphate exposures that could have influenced 
AChE. Hence, we will base our validation on the subjective organophosphate exposure within the last 82 days 
before the phase 3 examination, and on the AChE measurement in phase 3. We have to weight each exposure 
in this time window according to the time that has elapsed since the exposure, and the weighting strategy is 
described in details below. 
We expect the RBC inhibition to decrease (or in other words, the enzyme activity to increase towards normal) 
as a linear function of time since exposure.18 A schematic representation of this model is shown in Figure 2, 
where a single exposure happens at time 0, and trecover is the time from exposure termination to normalization 
of RBC AChE. 
FIGURE 2: MODEL OF RBC ACHE AS FUNCTION OF TIME AFTER A SINGLE EXPOSURE TO A SINGLE ORGANOPHOSPHATE 
INSECTICIDE 
 
 
In the following, D will denote the inhibition/decrease of RBC AChE relative to the normal, in percent: 
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EQUATION 10-1 
𝐷𝐷 = 𝐴𝐴𝐴𝐴ℎ𝐸𝐸𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 − 𝐴𝐴𝐴𝐴ℎ𝐸𝐸 
At time 0, we will assume that the degree of inhibition is the product of the absorbed dose of organophosphate 
insecticide and its absolute potency (𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑛𝑛𝑎𝑎𝑎𝑎 = its ability to inhibit the enzyme at a given dose). In section 
10.4.3, we describe how the absorbed dose is a function of the external exposure to the compound and the 
use of personal protective equipment, and in section 10.4.2 we further explain the concept of potency. 
EQUATION 10-2 
𝐷𝐷(0) = 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑛𝑛𝑎𝑎𝑎𝑎 × 𝑑𝑑𝑝𝑝𝑑𝑑𝑝𝑝 
Inspecting Figure 2, we can derive the following three equations for D as a function of time after exposure 
(t): 
EQUATION 10-3 
𝐷𝐷(𝑝𝑝) =
⎩
⎨
⎧
0 𝑓𝑓𝑝𝑝𝑓𝑓 𝑝𝑝 < 0
𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑛𝑛𝑎𝑎𝑎𝑎 × 𝑑𝑑𝑝𝑝𝑑𝑑𝑝𝑝 − 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑛𝑛𝑎𝑎𝑎𝑎 × 𝑑𝑑𝑝𝑝𝑑𝑑𝑝𝑝𝑝𝑝𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛 × 𝑝𝑝 𝑓𝑓𝑝𝑝𝑓𝑓 𝑝𝑝 ∈ [0, 𝑝𝑝𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛]0 𝑓𝑓𝑝𝑝𝑓𝑓 𝑝𝑝 > 𝑝𝑝𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛  
We can rewrite this as 
EQUATION 10-4 
𝐷𝐷(𝑝𝑝) = 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑛𝑛𝑎𝑎𝑎𝑎 × 𝑑𝑑𝑝𝑝𝑑𝑑𝑝𝑝 × � 0 𝑓𝑓𝑝𝑝𝑓𝑓 𝑝𝑝 < 01 − 𝑝𝑝𝑝𝑝𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛  𝑓𝑓𝑝𝑝𝑓𝑓 𝑝𝑝 ∈ [0, 𝑝𝑝𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛]0 𝑓𝑓𝑝𝑝𝑓𝑓 𝑝𝑝 > 𝑝𝑝𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛  
Therefore, we define the time weight w as the last factor in Equation 10-4: 
EQUATION 10-5 
𝑤𝑤 = � 0 𝑓𝑓𝑝𝑝𝑓𝑓 𝑝𝑝 < 01 − 𝑝𝑝
𝑝𝑝𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛
 𝑓𝑓𝑝𝑝𝑓𝑓 𝑝𝑝 ∈ [0, 𝑝𝑝𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛]0 𝑓𝑓𝑝𝑝𝑓𝑓 𝑝𝑝 > 𝑝𝑝𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛  
Where t is the number of days since exposure and trecover is the number of days it takes for AChE to revert to 
normal after a single organophosphate exposure. Human data for workers exposed to dichlorvos suggest the 
best estimate is 𝑝𝑝𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛𝑟𝑟𝑟𝑟𝑛𝑛 = 82, but with a 95% CI ranging from 72 to 98.18 We will use the best estimate in the 
primary analysis, but perform sensitivity analyses with both the upper and lower limit of the 95% CI. 
10.4.2 Weighting factor for potency of each organophosphate insecticide 
Before we try to correlate organophosphate insecticide exposures with AChE measurements, the exposures 
must be weighted not only by the time since exposure, but also by the potency of the compound (i.e., its ability 
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to induce acetylcholine esterase inhibition), as the potencies of different organophosphate insecticides can 
vary by up to four orders of magnitude (see below). The absolute potency is defined in Equation 10-2. 
Based on published data from animal experiments, the US EPA has published lists of the relative oral potencies 
(i.e., the potency compared to that of methamidophos) of a number of organophosphate insecticides, based 
on both brain19 and RBC20 (red blood cell) enzyme isoforms. The potencies are listed in Table 3. In the primary 
model, we will weight exposures by their relative RBC potency, while the brain potency will be used in 
secondary analyses. For some compounds, only the brain potency was available from the US EPA. In these 
cases, we have predicted the RBC potency as a function of the brain potency and the lipofilicity of the 
compound, as detailed in Appendix A. Potential parameters for the prediction model were chosen based on 
literature.21 
TABLE 3: RELATIVE POTENCIES OF ORGANOPHOSPHATE INSECTICIDES REGARDING ACHE INHIBITION  
Relative potency 
Brain Red blood cells 
Acephate 0.08 0.0211 
 
Azinphos-methyl 0.1 0.3504 
 
Bensulide 0.003 0.0113 
 
Chlorethoxyfos 0.13 0.7357 * 
Chlorpyrifos 0.06 0.1002 
 
Chlorpyrifos-methyl 0.005 0.0255 * 
Diazinon 0.01 0.2205 
 
Dichlorvos 0.03 0.1453 
 
Dicrotophos 1.91 2.1779 * 
Dimethoate 0.32 0.4187 
 
Disulfoton 1.26 4.5647 
 
Ethoprop 0.06 0.2397 * 
Fenamiphos 0.04 0.6504 
 
Fenthion 0.33 1.5692 * 
Fosthiazate 0.07 0.3964 
 
Malathion 0.0003 0.0041 
 
Methamidophos 1 1.0969 
 
Methidathion 0.32 0.2658 
 
Methyl-parathion 0.12 0.2690 
 
Mevinphos 0.76 0.5391 
 
Naled 0.08 0.0326 
 
Omethoate 0.93 0.7751 * 
Oxydemeton-methyl 0.86 0.5741 
 
Phorate 0.39 3.5171 
 
Phosalone 0.01 0.0722 
 
Phosmet 0.02 0.1296 
 
Phostebupirim 0.22 1.0832 * 
Pirimiphos-methyl 0.04 0.0326 
 
Profenofos 0.004 0.0234 * 
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Terbufos 0.85 2.9736 
 
Tetrachlorvinphos 0.001 0.0028 
 
Tribufos 0.02 0.2493 
 
Trichlorfon 0.003 0.0047 
 
* = RBC potency estimated as detailed in Appendix A. 
10.4.3 Weighting factor for use of personal protective equipment and hygienic 
measures 
In phase 1 of the PEXADU project, all participants in the PEXADU project who reported that they had ever 
sprayed or mixed pesticides were asked how often they used each of the following categories of personal 
protective equipment (PPE), among others, when handling pesticides: 
• Dust mask 
• Mask with carbon filter 
• Goggles 
• Gloves 
• Long-sleeved shirt 
• Rubber apron 
• Rain poncho 
• Overalls 
• Long pants 
• Gaiters 
• Water proof pants 
• Rubber boots 
For each of each of these kinds of PPE, participants were asked how often they used them. The following 
categories were available as answers: 
• Always (100%) 
• Often (75%) 
• Sometimes (50%) 
• Rarely (25%) 
• Never (0%) 
Participants could also state “I don’t know” or refuse to answer the question.  If participants stated in phase 1 
that they had never used pesticides, yet stated in phase 2 or 3 that they had used pesticides since the last 
examination, we do not have any information on their use of PPE. In the primary analysis, the missing values 
will be replaced with values imputed based on a linear regression model of PPE use vs. participant sex, age 
and farmer’s organization (conventional farmer’s group vs. semi-organic farmer’s group) among the 
participants where the information is available. In sensitivity analyses, participants with any missing 
information will be excluded. 
We will assume that the protection offered by the protective equipment can be expressed as a weighting 
factor PPE. Furthermore, we assume that the PPE protection factor is the sum of the protection offered to six 
different body parts: 
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𝑃𝑃𝑃𝑃𝐸𝐸 = 𝑃𝑃𝑃𝑃𝐸𝐸𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈 + 𝑃𝑃𝑃𝑃𝐸𝐸𝑈𝑈𝑈𝑈𝑈𝑈 + 𝑃𝑃𝑃𝑃𝐸𝐸𝑀𝑀𝑈𝑈𝑈𝑈𝑀𝑀𝑀𝑀 + 𝑃𝑃𝑃𝑃𝐸𝐸𝑀𝑀𝐻𝐻𝐻𝐻𝑈𝑈 + 𝑃𝑃𝑃𝑃𝐸𝐸𝐿𝐿𝑈𝑈𝐿𝐿 + 𝑃𝑃𝑃𝑃𝐸𝐸𝐹𝐹𝑈𝑈𝑈𝑈𝑀𝑀  
This formula is based on an existing pesticide exposure score developed for use among small-holder farmers 
in Costa Rica.22 Each type of PPE is assumed to protect a specific part of the body only, and lowers exposure 
to that body part by a specific fraction, estimated from literature.  Deterministic exposure scores for different 
types of PPE are seen in Table 4. If a participant has reported use of two kinds of PPE that protect the same 
body part, we will base our calculations on the PPE that protects the most. 
Participants were also asked how soon after pesticide exposure they showered and changed their clothes. The 
protection factor offered by these hygienic measures are seen in Table 5.  
10.4.4 Creating the deterministic model: 
As suggested in previous work,22 for each organophosphate insecticide reported by participants, we will 
assume that the intensity of external pesticide exposure per session is a function of both preparing/mixing the 
compound (denoted MIX below) and  applying it (APPLY): 
𝐼𝐼𝐼𝐼𝐼𝐼𝐸𝐸𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝑈𝑈𝐸𝐸𝑀𝑀𝑈𝑈𝑈𝑈𝐻𝐻𝐻𝐻𝐿𝐿 = 𝑀𝑀𝐼𝐼𝑀𝑀 + 𝐴𝐴𝑃𝑃𝑃𝑃𝐴𝐴𝐼𝐼 
The magnitude of the internal intensity per exposure is the intensity of external exposure, multiplied by factors 
accounting for the use of personal protective equipment, changing clothes (CHANGE) and/or showering 
(SHOWER) after handling pesticides:22 
𝐼𝐼𝐼𝐼𝐼𝐼𝐸𝐸𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐻𝐻𝑀𝑀𝑈𝑈𝑈𝑈𝐻𝐻𝐻𝐻𝐿𝐿 = 𝐼𝐼𝐼𝐼𝐼𝐼𝐸𝐸𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝑈𝑈𝐸𝐸𝑀𝑀𝑈𝑈𝑈𝑈𝐻𝐻𝐻𝐻𝐿𝐿 × 𝑃𝑃𝑃𝑃𝐸𝐸 × 𝐴𝐴𝐶𝐶𝐴𝐴𝐼𝐼𝐶𝐶𝐸𝐸 × 𝐼𝐼𝐶𝐶𝑆𝑆𝑆𝑆𝐸𝐸𝑆𝑆 
As described above, the degree of acetylcholine inhibition induced by the exposure is the product of the 
potency of the compound, a weighting factor w taking into account the amount of time since the exposure, 
and the internal intensity of the exposure: 
𝐷𝐷(𝑝𝑝) = 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑛𝑛𝑎𝑎𝑎𝑎 × 𝐼𝐼𝐼𝐼𝐼𝐼𝐸𝐸𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐻𝐻𝑀𝑀𝑈𝑈𝑈𝑈𝐻𝐻𝐻𝐻𝐿𝐿 × 𝑤𝑤 
 
In the study population, participants were reported exposed to multiple different organophosphate 
insecticides, and exposure was repeated (rather than at a single point in time). We will assume that the 
inhibition caused by these exposures is additive: 
EQUATION 10-6 
𝐷𝐷(𝑝𝑝)𝑡𝑡𝑛𝑛𝑡𝑡𝑛𝑛𝑛𝑛 = �𝐷𝐷(𝑝𝑝)𝑖𝑖,𝑗𝑗
𝑖𝑖,𝑗𝑗  
Where 𝐷𝐷(𝑝𝑝)𝑖𝑖,𝑗𝑗  us the inhibition caused by the ith exposure to the jth organophosphate insecticide compound. 
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Since we do not know the absolute potency of all included organophosphates, but rather the relative 
potency, we will use the latter instead. The final deterministic exposure score SCORE that we will validate 
against the measured AChE activity is therefore given by Equation 10-7: 
EQUATION 10-7 
𝐼𝐼𝐴𝐴𝑆𝑆𝑆𝑆𝐸𝐸 = 𝑃𝑃𝑃𝑃𝐸𝐸 × 𝐴𝐴𝐶𝐶𝐴𝐴𝐼𝐼𝐶𝐶𝐸𝐸 × 𝐼𝐼𝐶𝐶𝑆𝑆𝑆𝑆𝐸𝐸𝑆𝑆 × (𝑀𝑀𝐼𝐼𝑀𝑀 + 𝐴𝐴𝑃𝑃𝑃𝑃𝐴𝐴𝐼𝐼) × �𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑛𝑛𝑟𝑟𝑛𝑛,𝑗𝑗 × 𝑤𝑤𝑖𝑖
𝑖𝑖,𝑗𝑗  
10.4.4.1 Information that will not be included in the deterministic model 
The deterministic model will not include time spent farming in general (excluding the time working with 
pesticides), and whether other people on the farm use pesticides. While we do have this information from 
participant interviews, we cannot use it to obtain data on specific pesticidal compounds or classes of 
compounds. We recognize that pesticide exposure during work in pesticide-treated fields or stables can be 
significant, but we will focus on compound-specific information regarding participant’s own use of pesticides, 
as we deem that more helpful in the assessment of health effects of specific pesticides. 
We will also not include information on the use of insecticide-treated mosquito nets, even though this 
information is also available from the interviews. In phase 1, 313 out of 364 participants (86%) reported that 
they had used an insecticide-treated net within the last year, but only 19 persons (5%) reported that more 
pesticide was ever applied to the nets. Unfortunately, we did not ask participants with which insecticides their 
mosquito net was treated (if so). The insecticides recommended by the WHO for use on mosquito nets are 
pyrethroid insecticides,23 24 but any participants retreating their own nets at home may have used different 
insecticides.  Because of the lack of compound-specific data and the low number of persons reporting re-
treatment of the nets, it would be hard to validate an exposure score including mosquito nets against 
biomarkers of insecticide exposure. 
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TABLE 4: DETERMINISTIC EXPOSURE SCORES FOR DIFFERENT KINDS OF PPE 
Exposure pathway Inhalation Dermal exposure Whole 
body Body part Mouth Eyes Hands Upper body Legs Feet 
Relative contribution in 
case no PPE is used 0.1 0.1 0.4 0.2 0.1 0.1 1 
Type of PPE Dust mask 
Mask with 
carbon filter Goggles Gloves 
Overall or long-
sleeved shirt 
Rubber apron 
or rain poncho 
Overall or 
long pants 
Gaiters or 
water-proof 
pants 
Rubber 
boots   
PPE quality W NWP NWP W or NWP W NWP W NWP NWP   
Fractional exposure when 
using PPE                     
All the time (100%) 0.30 0.10 0.10 0.20 0.30 0.10 0.30 0.10 0.10   
Most of the time (75%) 0.48 0.33 0.33 0.40 0.48 0.33 0.48 0.33 0.33   
Often (50%) 0.65 0.55 0.55 0.60 0.65 0.55 0.65 0.55 0.55   
Rarely (25%) 0.83 0.78 0.78 0.80 0.83 0.78 0.83 0.78 0.78   
Never (0%) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00   
Actual exposure score: 
Example for best possible 
protection 
0.03 0.01 0.01 0.08 0.06 0.02 0.03 0.01 0.01 0.14 
W = woven. NWP = non-woven permeable 
Protection factors from 22 
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TABLE 5: DETERMINISTIC EXPOSURE SCORES FOR BEHAVIORAL FACTORS 
Variable Deterministic exposure score Reference 
MIX 5 if mixing pesticides, otherwise 0 Thomas et al 201025 
APPLY 8 if applying pesticides, otherwise 0 Thomas et al 201025 
CHANGE 
Next day: 1 
Dosemeci et al 
200226 
Many hours later: 0.9 
A few hours later: 0.8 
Immediately or within one hour: 0.7 
SHOWER 
Next day: 1 
Dosemeci et al 
200226 
Many hours later: 0.9 
A few hours later: 0.8 
Immediately or within one hour: 0.7 
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10.5 Description of the empirical model 
As described above, the deterministic model will make many assumptions regarding the ways that exposure 
to organophosphates is related to AChE (time, potency, PPE, hygienic factors). We will therefore also develop 
a simple empirical model containing fewer variables. The size of the influence of these variables on AChE will 
be determined in a linear mixed effect model. 
As we have too little data to create compound-specific models for all reported organophosphate insecticides, 
we will calculate the sum of the potency-adjusted number of times individual organophosphate insecticides 
were used between phases 1 and 3. 
EQUATION 10-8 
𝐼𝐼𝐼𝐼𝑀𝑀𝐸𝐸𝐼𝐼𝑡𝑡𝑛𝑛𝑡𝑡𝑛𝑛𝑛𝑛 = �𝐼𝐼𝐼𝐼𝑀𝑀𝐸𝐸𝐼𝐼𝑗𝑗 × 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑛𝑛𝑟𝑟𝑛𝑛,𝑗𝑗
𝑗𝑗
 
Where TIMEStotal is the potency-adjusted number of times of use, TIMESj is the number of times that the jth 
organophosphate insecticide has been used, and potencyrel,j is its relative potency. The relative potencies of 
each organophosphate insecticide can be seen above in section 10.4.2. We will take into account all 
organophosphate exposure between phases 1 and 3, but not consider the time from exposure to the phase 3 
examination. 
We will assume that using a specific type of PPE will reduce exposure by a fraction proportional to the 
frequency of usage of that PPE: 
𝐼𝐼𝐼𝐼𝐼𝐼𝐸𝐸𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐻𝐻𝑀𝑀𝑈𝑈𝑈𝑈𝐻𝐻𝐻𝐻𝐿𝐿 = 𝐼𝐼𝐼𝐼𝑀𝑀𝐸𝐸𝐼𝐼𝑡𝑡𝑛𝑛𝑡𝑡𝑛𝑛𝑛𝑛 × �1 −∝𝑈𝑈𝑈𝑈𝑈𝑈_0× 𝑓𝑓𝑈𝑈𝑈𝑈𝑈𝑈_0� 
Where ∝𝑈𝑈𝑈𝑈𝑈𝑈,0 is the protection offered by PPE_0 if it was used 100% of the time when handling pesticides, 
and 𝑓𝑓𝑈𝑈𝑈𝑈𝑈𝑈_0 is the fraction of time that PPE_0 is actually used. This can be rewritten as: 
𝐼𝐼𝐼𝐼𝐼𝐼𝐸𝐸𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐻𝐻𝑀𝑀𝑈𝑈𝑈𝑈𝐻𝐻𝐻𝐻𝐿𝐿 = 𝐼𝐼𝐼𝐼𝑀𝑀𝐸𝐸𝐼𝐼𝑡𝑡𝑛𝑛𝑡𝑡𝑛𝑛𝑛𝑛 −∝𝑈𝑈𝑈𝑈𝑈𝑈_0× 𝑓𝑓𝑈𝑈𝑈𝑈𝑈𝑈_0 × 𝐼𝐼𝐼𝐼𝑀𝑀𝐸𝐸𝐼𝐼𝑡𝑡𝑛𝑛𝑡𝑡𝑛𝑛𝑛𝑛  
Based on analyses of Directed Acyclic Graphs (see Appendix C, section 17.1.1) we will also include the three 
following predictors of AChE:  
• Age (continuous variable). Can influence AChE independently of organophosphate exposure,27 and 
may determine actual exposure. 
• Sex. Can influence AChE independently of organophosphate exposure,27 and may determine actual 
exposure. 
• Years of schooling (continuous variable, proxy for socioeconomic status). 
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10.6 Running the analyses in Stata 
10.6.1 Primary analysis 
10.6.1.1 Deterministic model 
To validate the deterministic model, we will first calculate the deterministic score SCORE as detailed in 
Equation 10-7. We will then run a linear mixed effect model with AChE as the dependent variable and SCORE 
as the independent variable. Age, sex and years of schooling (proxy for socioeconomic status) will be included 
as covariates, as analysis of a Directed Acyclic Graph suggests that they are can influence the relationship 
between exposure and AChE (see Appendix C, section 17.1.1). 
SCORE, age and years of schooling will be modelled using restricted cubic splines with four knots (location 
determined by the distributions of the variables), as implemented in the Stata command ‘mkspline’: 
mkspline age_spline = age, cubic nknots(4) 
mkspline years_school_spline = years_school, cubic nknots(4) 
mkspline score_spline = score, cubic nknots(4) 
The linear mixed effects model (with fixed effects only) can then be run using the following command: 
mixed ache c.score_spline* c.age_spline* c.years_school_spline* i.male ||, reml 
The performance of model will primarily be evaluated using the residual variance, compared to the total AChE 
variance (lower residual variance is better). But the evaluation will also include QQ-plot and histogram of 
residuals, as well as Bland-Altmann plots. 
10.6.1.2 Empirical model 
We only have sufficient data to include one kind of PPE in our empirical model, and we will not make any a 
priori assumptions about which kind of PPE best predicts exposure. E.g., using a mask with a carbon filter likely 
protects better than a simple dust mask, but if almost no one uses masks with carbon filters, we cannot predict 
AChE using this variable. To create the best possible empirical model, we will fit a number of linear fixed effect 
models, where each model includes a specific type of PPE. Each model will be run using a command of the 
following structure: 
gen ppe_adjusted_times = times_total * frequency_ppe 
mixed ache c.times_total c.ppe_adjusted_times c.age_spline* 
c.years_school_spline* i.male ||, reml 
The types of PPE considered are those mentioned in section 10.4.3. We will only build models for types of PPE 
that have been used by at least 15 people who also reported having used organophosphate insecticides 
between phases 1 and 3. 
Note that because of the limited amount of data available, we will assume that times_total and 
ppe_adjusted_times affect AChE in a linear manner. Age and years of schooling will be modelled using 
restricted cubic splines. 
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The performance of each model will be evaluated in the same manner as for the deterministic model. The final 
deterministic model is the one with the numerically lowest residual variance (we will not consider statistical 
significance when choosing the best model). 
10.6.1.3 Comparison 
To determine whether the deterministic or the empirical model has the highest explanatory power, we will 
compare the residual variance of the two models. The best model is the one with the numerically lowest 
residual variance. We will not consider whether any difference between the models is statistically significant. 
10.6.2 Secondary analysis 
As seen above, the primary analyses are multivariate. The models will be supplemented with the following 
simpler models: 
10.6.2.1 Deterministic model with exposure metric only 
Stata code 
mixed ache c.score_spline* ||, reml 
10.6.2.2 Empirical model with exposure metric only 
Stata code 
mixed ache c.times_total c.ppe_adjusted_times ||, reml 
10.6.2.3 Model only including non-insecticide determinants of AChE 
Stata code 
mixed ache c.age_spline* c.years_school_spline* i.male ||, reml 
10.6.3 Sensitivity analyses 
10.6.3.1 Sensitivity analysis # 1 
In this sensitivity analysis, we will re-analyze the primary deterministic model (described in section 10.6.1.1). 
But instead of weighting each organophosphate compound by its relative potency for AChE inhibition in RBC, 
we will use its potency in brain (see Table 3). 
10.6.3.2 Sensitivity analysis # 2 
In the primary deterministic model, the time from organophosphate exposure to total recovery of AChE is 
assumed to be 82 days. When we do not know the exact date of an exposure with size E, we will model it as n 
repeated exposures of size E/n, where n is the number of possible dates where it could have happened. 
To test the robustness of the model, it will be re-analyzed under the following four scenarios: 
1. Recovery time = 72 days. Otherwise similar to primary deterministic model. 
2. Recovery time = 98 days. Otherwise similar to primary deterministic model. 
3. Recovery time = 82 days. If an exposure E has happened in an interval of n days, we will model it as a 
point exposure on the first of these days. 
4. Recovery time = 82 days. If an exposure E has happened in an interval of n days, we will model it as a 
point exposure on the last of these days. 
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10.6.3.3 Sensitivity analysis # 3 
In this sensitivity analysis, we will rerun the primary analysis, assuming linearity between organophosphate 
insecticide exposure, age and AChE. I.e., we will not use splines. In Stata, the models will be run like this: 
mixed ache c.score c.age c.years_school i.male ||, reml 
mixed ache c.times_total c.ppe_adjusted_times c.age c.years_school i.male ||, 
reml 
The performance of the models will be evaluated in the same way as in the primary analysis. 
10.6.3.4 Sensitivity analysis # 4 
In this sensitivity analysis, we will not impute missing information on hygienic practices or use of PPE. Instead, 
we leave out persons with missing information in any of the variables in the model. 
10.6.3.5 Sensitivity analysis # 5 
During data collection, AChE measurements were repeated for a few people. This was done when the primary 
investigator suspected that measurements were erroneous, e.g. in case of very high or very high values for 
either AChE or hemoglobin, as this could indicate that a mistake might have happened during the sample 
analysis. While the decision to repeat the analysis was not wittingly based on participant's pesticide exposure 
levels, it is possible that the decision could have been subconsciously biased. Therefore, in the main analyses 
we will use the first AChE value for each person in a given phase, no matter if we think that value is correct or 
not. Any errors in these data are expected to be non-differential and therefore unable to introduce bias into 
or results. As a sensitivity analysis, we will repeat the primary analysis (recreating both the deterministic and 
the empirical models), but this time using the AChE value we deem most likely to be correct. This judgment 
will be based on the consistency between all AChE and hemoglobin values from each phase. 
10.6.3.6 Sensitivity analysis # 6 
Preliminary descriptive analyses have shown that participants used a considerable amount of other pesticides, 
apart from organophosphate insecticides (date not shown). To investigate whether participants were able to 
accurately report compound-specific pesticide usage data, we will repeat the primary analysis, but using all 
other classes of pesticides than organophosphate insecticides as the relevant exposure. A priory, we do not 
expect these other pesticides to be able to inhibit AChE. Exposure to different classes of chemical is expected 
to covariate. However, if participants were able to reliably report compound-specific data, we expect the 
residual variance in these models to be higher than in the primary analyses. 
As we have no a priori expectations that other classes of pesticides than organophosphates (or carbamates) 
can inhibit AChE, we will not weight the amounts of these other pesticides by any potency factor. 
10.6.3.7 Sensitivity analysis # 7 
In this sensitivity analysis, we will not only take into account the number of times that participants have 
handled organophosphate insecticides, but also the amount of each compound used each time. 
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We will thus define the deterministic exposure score as  
𝐼𝐼𝐴𝐴𝑆𝑆𝑆𝑆𝐸𝐸 = 𝑃𝑃𝑃𝑃𝐸𝐸 × 𝐴𝐴𝐶𝐶𝐴𝐴𝐼𝐼𝐶𝐶𝐸𝐸 × 𝐼𝐼𝐶𝐶𝑆𝑆𝑆𝑆𝐸𝐸𝑆𝑆 × (𝑀𝑀𝐼𝐼𝑀𝑀 + 𝐴𝐴𝑃𝑃𝑃𝑃𝐴𝐴𝐼𝐼) × �𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑛𝑛𝑟𝑟𝑛𝑛,𝑗𝑗 × 𝐴𝐴𝑀𝑀𝑆𝑆𝐴𝐴𝐼𝐼𝐼𝐼𝑖𝑖 × 𝑤𝑤𝑖𝑖
𝑖𝑖,𝑗𝑗  
Where AMOUNTi is the amount used of organophosphate j during exposure i. 
In the empirical model, we will replace the potency-adjusted number of times of exposure (TIMEStotal) with the 
potency-adjusted amount of organophosphate insecticide used (AMOUNTtotal): 
𝐴𝐴𝑀𝑀𝑆𝑆𝐴𝐴𝐼𝐼𝐼𝐼𝑡𝑡𝑛𝑛𝑡𝑡𝑛𝑛𝑛𝑛 = �𝐴𝐴𝑀𝑀𝑆𝑆𝐴𝐴𝐼𝐼𝐼𝐼𝑗𝑗 × 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑛𝑛𝑟𝑟𝑛𝑛,𝑗𝑗
𝑗𝑗
 
Where AMOUNTj is the amount used of the jth insecticide. 
10.6.3.8 Sensitivity analysis # 8 
As previously described, our outcome of interest is red blood cell acetylcholine esterase activity, expressed in 
units of enzyme activity per gram hemoglobin (U/g). In phase 1 of the PEXADU project, we noticed an apparent 
discrepancy between hemoglobin values reported by the Test-Mate AChE system and hemoglobin values 
measured with a clinical hemoglobinometer in a subsample of participants (data not shown). Our results 
indicated that the Test-Mate might be underestimating the hemoglobin levels. As the difference was 
systematic, it was possible to derive an adjustment equation. 
To investigate whether inaccuracy in the Test-Mate hemoglobin values could have any considerable effects on 
our models, we will repeat our primary analyses after normalizing the acetylcholine esterase activity with the 
adjusted hemoglobin values (calculated using before-mentioned equation). 
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11 Analysis plan for glycemic regulation 
The exposure models used in analyses of pesticide exposure vs. glycemic regulation will depend on results 
from the analyses of organophosphate exposure vs. AChE activity. The analysis plan for glycemic regulation 
will therefore be written once these results are ready. 
We will present both raw and adjusted results. In our adjusted analyses, we will adjust for age, socioeconomic 
status and sex. These confounders have been selected a priori based on Directed Acyclic Graphs,28 as described 
in Appendix C, section 17.2. 
12 Analysis plan for lung function tests 
The exposure models used in analyses of pesticide exposure vs. lung function tests will depend on results from 
the analyses of organophosphate exposure vs. AChE activity. The analysis plan for lung function tests will 
therefore be written once these results are ready. 
We will present both raw and adjusted results. In our adjusted analyses, we will adjust for age, socioeconomic 
status and sex. These confounders have been selected a priori based on Directed Acyclic Graphs,28 as described 
in Appendix C, section 17.3. 
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13 Analysis plan for validation of Vitalograph copd-6 
13.1 Purpose 
To evaluate the accuracy and precision on the Vitalograph copd-6 mini-spirometer in a Ugandan population. 
Spirometry is an important examination in clinical practice, as well as in studies of occupational and 
environmental determinants of poor lung function. However, diagnostic-quality spirometers can be 
prohibitively expensive for use in developing countries such as Uganda. The mini-spirometer Vitalograph 
copd-629 is marketed as screening device for COPD30 and is much cheaper than diagnostic-quality 
spirometers. We wanted to examine whether the copd-6 is sufficiently accurate and precise to allow future 
studies on pulmonary health in Uganda to rely only on the copd-6. 
13.2 Statistical procedures 
After a test, the copd-6 reports FEV1 and FEV6. Analyses will be based on FEV1 and FEV6 as continuous 
variables. Due to a low number of study participants with airway obstruction, we have insufficient statistical 
strength to examine the sensitivity and specificity of the copd-6 for the diagnosis of obstruction. 
13.2.1 Descriptive statistics 
In phase 1, participants eligible for spirometry performed spirometry both with the diagnostic-quality device 
MicroMedical MicroDL and with the copd-6. 
We will start by creating a table with the following descriptive metrics: 
 MicroDL 
copd-6 
Before MicroDL After MicroDL Total 
Number of persons n n n n 
Number of blows 
per person 
Median (95% PI) Median (95% PI) Median (95% PI) Median (95% PI) 
FEV1 (l) Median (95% PI) Median (95% PI) Median (95% PI) Median (95% PI) 
FEV6 (l) 
[Not reported by 
device] 
Median (95% PI) Median (95% PI) Median (95% PI) 
FVC (l) Median (95% PI) 
[Not reported by 
device] 
[Not reported by 
device] 
[Not reported by 
device] 
It should be noted that the MicroDL reports FEV1 and FVC, while the copd-6 reports FEV1 and FEV6. 
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“Before MicroDL” and “After MicroDL” means that a participant was tested with the copd-6 before or after 
being tested with the MicroDL, respectively. Data are presented separately for the two conditions, as the 
order of testing may influence results (learning effects, fatigue, etc.). 
Continuous data will be presented as median rather than mean/average, as data may be non-normally 
distributed. Non-normally distributed data will be transformed to obtain normality, and summary metrics 
back-transformed to the original scale. 
13.2.2 Primary analysis 
For each participant, we will calculate the difference in FEV1 measured by the copd-6 and the MicroDL: 
∆𝐹𝐹𝐸𝐸𝐹𝐹1 = 𝐹𝐹𝐸𝐸𝐹𝐹1,𝑟𝑟𝑛𝑛𝑐𝑐𝑐𝑐6 − 𝐹𝐹𝐸𝐸𝐹𝐹1,𝑀𝑀𝑖𝑖𝑟𝑟𝑛𝑛𝑛𝑛𝑈𝑈𝐿𝐿 
We will report the following summary measures for ∆𝐹𝐹𝐸𝐸𝐹𝐹1 : 
• Median 
• Range 
• 95% confidence interval for median 
• Interquartile range 
• 95% prediction interval for median 
The median with 95% confidence interval will serve as an overall test of statistically significant differences in 
FEV1 between copd-6 and MicroDL. 
Trends in ∆𝐹𝐹𝐸𝐸𝐹𝐹1 as a function of FEV1 will be depicted using a Bland-Altman plot as shown below (the data in 
the example figure are pseudo-random and do not come from the actual dataset): 
 
Median
25th percentile
75th percentile
FE
V 1
,c
op
d6
 - 
FE
V
1,
M
ic
ro
D
L
(FEV1,copd6 + FEV1,MicroDL) / 2
Bland-Altman plot: FEV1,copd6 vs. FEV1,MicroDL
Analysis protocol: Pesticide Exposure, Asthma and Diabetes in Uganda (PEXADU) 
 
Page 36 of 78 
To assess whether any bias in measurements from the copd-6 depends of the size of FEV1, we will perform a 
linear regression with ΔFEV1 as dependent variable and 𝐹𝐹𝐸𝐸𝐹𝐹1������� = 𝐹𝐹𝐸𝐸𝐹𝐹1,𝑟𝑟𝑛𝑛𝑐𝑐𝑐𝑐6 − 𝐹𝐹𝐸𝐸𝐹𝐹1,𝑀𝑀𝑖𝑖𝑟𝑟𝑛𝑛𝑛𝑛𝑈𝑈𝐿𝐿 as independent 
variable. We will take non-linearity into account by modelling 𝐹𝐹𝐸𝐸𝐹𝐹1������� using restricted cubic splines with four 
knots. The location on the knots will depend on the distribution of the data, as implemented in the Stata 
command mkspline. 
 
13.2.3 Secondary analyses 
13.2.3.1 Analysis stratified by order of testing 
Because of learning effects, fatigue, etc., results may depend on the order of testing (MicroDL first or copd-6 
first). Therefore, the primary analysis will be repeated, stratified by order of testing.  
13.2.3.2 Analysis of calibration check data 
On each day of spirometric testing in phase 1, the calibration of the copd-6 devices was checked using a 3-
liter calibration syringe. The syringe was emptied under three conditions: 
1) Fast: As fast as possible without banging the piston against the wall of the syringe. 
2) Slow: As slow as possible while finishing within 6 seconds (the copd-6 gave an auditory signal after 6 
seconds). 
3) Medium: Piston pushed at speed in-between 1 and 2 
We emptied the syringe three times under each condition and recorded both the FEV1, FEV6 and FEV1/FEV6 
reported by the device. 
According to ATS criteria, spirometers must measure volumes with an accuracy of ±3 percent15. We will 
check the validity of the copd-6 by creating a scatterplot of the reported FEV6 (which should theoretically be 
3.00 liters, if there was zero imprecision) as a function of the reported FEV1 (which is a measure of the speed 
at which the piston was pushed). The data points will have different symbols to show whether the test 
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condition was fast/medium/slow. An example with pseudo-random data is shown below:
 
In addition to the graphical representation, precision and validity will also be assessed by drawing the 
following table: 
 
Subjective flow speed Total 
Slow Medium Fast  
Measurements n n n n 
Reported FEV1 (l) Median (95% CI) Median (95% CI) Median (95% CI) Median (95% CI) 
Reported FEV6 (l) Median (95% CI) Median (95% CI) Median (95% CI) Median (95% CI) 
Measurements with FEV6 < 2.91 l n (%) n (%) n (%) n (%) 
Measurements with FEV6 > 3.09 l n (%) n (%) n (%) n (%) 
Any trend in accuracy as a function of subjective flow speed will be assessed by Spearman’s rank correlation 
of reported FEV6 vs. flow speed (1 = slow, 2 = medium, 3 = fast). 
13.2.3.3 Analysis based on FEV6 and FVC instead of FEV1 
We will repeat the primary analysis, based on FEV6 and FVC instead of FEV1. The Vitalograph copd-6 device 
reports FEV6, while the MicroMedical MicroDL reports FVC. Those two lung function indices are not directly 
comparable, unless a blow has taken ≤ 6 seconds from start to finish. A blow with duration ≤ 6 seconds, where 
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the volume-time curve has reached a plateau at the end of the blow, will have FEV6 = FVC. Therefore, this 
analysis will be limited to those persons where all acceptable blows with the MicroDL took ≤ 6 seconds 
(without adjusting for slow starts). 
13.2.4 Sensitivity analyses 
13.2.4.1.1 REPEATED PRIMARY ANALYSIS, STRATIFIED BY DEVICES USED 
Two different copd-6 devices and a number of different MicroDL devices were used in the project. To check 
whether any imprecision or inaccuracy in the copd-6 results was due to differences in calibration or any faulty 
devices (copd-6 or MicroDL), we will repeat the primary analysis stratified by the combination of devices used. 
E.g., copd-6 device number 1 + MicroDL device number 3. Only stratums with at least 15 observations will be 
analyzed. Out of these, linear regression analysis of ∆𝐹𝐹𝐸𝐸𝐹𝐹1as a function of  𝐹𝐹𝐸𝐸𝐹𝐹1������� will only be carried out if 
there is at least 4 × 15 = 60 observations in the stratum. 
13.2.4.1.2 ANALYSIS OF CALIBRATION CHECK DATA, STRATIFIED BY DAY AND DEVICE 
Two different copd-6 devices were used in the project. To check whether any imprecision or inaccuracy in the 
calibration check data was due to temperature differences between days, spirometer turbines wearing down, 
differences in device calibration etc., the analyses of calibration check data will be repeated with simultaneous 
stratification by day of testing and device used. This analysis has already been carried out at the time of writing 
(June 11, 2019). 
13.2.4.1.3 REPEATED PRIMARY ANALYSIS, WITH ALTERNATIVE SPIROMETRY QUALITY CRITERIA 
When participants performed spirometry with the MicroMedical MicroDL device, they always got five 
attempts to start with. If, despite coaching from the nurse, their test did not fulfill ATS quality criteria15 after 
these five attempts, they were given an additional four attempts. The nurse coached participants based both 
on her/his observations of the participant during the test, and on the spirograms displayed by the spirometry 
software. When participants were tested with the Vitalograph copd-6 device, they were always given three 
attempts, no matter the quality of these. Coaching for the use of the copd-6 was based exclusively on the 
nurse’s observations of the participant, as the copd-6 cannot display spirograms. While the copd-6 manual 
does suggest testing until three good blows have been performed30, for pragmatic reasons we only asked 
participant to blow three times. This approach was chosen because we did not want to tire the participants 
(they already had to blow 8-12 times). The types of problems that the copd-6 can detect are slow start and 
cough.30 
In the primary analysis described above,  𝐹𝐹𝐸𝐸𝐹𝐹1,𝑀𝑀𝑖𝑖𝑟𝑟𝑛𝑛𝑛𝑛𝑈𝑈𝐿𝐿 will be based on all 5 or 9 blows from the MicroDL, with 
standard ATS quality criteria.15 The  𝐹𝐹𝐸𝐸𝐹𝐹1,𝑟𝑟𝑛𝑛𝑐𝑐𝑐𝑐6 will be the best FEV1 recorded with the copd-6, and will only 
be calculated if all three blows performed were OK according to the automatic classification by the device. 
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Hence, in the primary analysis we are comparing both across different devices and across different ways of 
testing. 
In this sensitivity analysis, we will apply similar quality criteria to both MicroDL and copd-6, to investigate if 
any discrepancies between the two devices in the primary analysis are due to different testing protocols or 
due to differences between the devices per se. For the MicroDL, we will only use the first three blows 
performed, and exclude blows where spirograms show slow start or cough. For the copd-6, we will use all 
three blows and exclude blows where the device showed a warning (because of either slow start or cough). 
We will base our analyses on only those participants who have three blows with the MicroDL and three blows 
with the copd-6 fulfilling these criteria. The values that we will compare are the best FEV1 out of the three 
measurements from each device. We will present overall results (corresponding to the analyses in section 
13.2.2) and stratified by the order of testing (corresponding to the analyses in section 13.2.3.1). 
14 Ethical considerations 
This study has been approved by the “Higher Degrees, Research and Ethics Committee” at Makerere University 
School of Public Health, Kampala, Uganda (protocol number 577). Is has also been approved by the “Uganda 
National Council for Science and Technology”, Kampala, Uganda (HS234ES). Since the proposed project is not 
carried out in Denmark, we were informed by The National Committee on Health Research Ethics in Denmark 
that approving the project fell outside their jurisdiction. The project has been registered with the Danish Data 
Protection Agency (Datatilsynet, www.datatilsynet.dk/english). 
The project was carried out in accordance with the Declaration of Helsinki. Participation was voluntary, and 
all participants signed an informed consent form before inclusion. Participant information was given in English 
or local language (Luganda) as appropriate. Participants were compensated for lost earnings, as well as travel 
and lunch expenses on the day of examination. 
At the time of writing, the biological materials collected during the PEXADU project were still stored in Uganda. 
We are in the process of getting permission from the Uganda National Council for Science and Technology 
(UNCST) to export the samples to Denmark for storage and analysis. 
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15 Appendix A: Deriviation of relative potencies for red blood cell 
acetylcholine esterase 
--------------------------------------------------------------------------------------------------------- 
      name:  <unnamed> 
       log:  C:\Users\au231481\Desktop\Potency EPA\predict_rbc_ache.log 
  log type:  text 
 opened on:   2 Aug 2019, 16:30:52 
 
.  
. //      Open table of brain ChE potency from USEPA 2006. List the data. 
.         import excel using "brain_che_potency_USEPA_2006.xlsx", firstrow clear 
 
.         rename Chemical chemical 
 
.         rename Oralrelativepotencybrain potency_brain 
 
.         label variable potency_brain "Relative potency, brain" 
 
.         sort chemical 
 
.         list, ab(32) 
 
     +-------------------------------------+ 
     |            chemical   potency_brain | 
     |-------------------------------------| 
  1. |            Acephate             .08 | 
  2. |     Azinphos-methyl              .1 | 
  3. |           Bensulide            .003 | 
  4. |      Chlorethoxyfos             .13 | 
  5. |        Chlorpyrifos             .06 | 
     |-------------------------------------| 
  6. | Chlorpyrifos-methyl            .005 | 
  7. |            Diazinon             .01 | 
  8. |          Dichlorvos             .03 | 
  9. |         Dicrotophos            1.91 | 
 10. |          Dimethoate             .32 | 
     |-------------------------------------| 
 11. |          Disulfoton            1.26 | 
 12. |            Ethoprop             .06 | 
 13. |          Fenamiphos             .04 | 
 14. |            Fenthion             .33 | 
 15. |         Fosthiazate             .07 | 
     |-------------------------------------| 
 16. |           Malathion           .0003 | 
 17. |       Methamidophos               1 | 
 18. |        Methidathion             .32 | 
 19. |    Methyl-parathion             .12 | 
 20. |           Mevinphos             .76 | 
     |-------------------------------------| 
 21. |               Naled             .08 | 
 22. |           Omethoate             .93 | 
 23. |   Oxydemeton-methyl             .86 | 
 24. |             Phorate             .39 | 
 25. |           Phosalone             .01 | 
     |-------------------------------------| 
 26. |             Phosmet             .02 | 
 27. |       Phostebupirim             .22 | 
 28. |   Pirimiphos-methyl             .04 | 
 29. |          Profenofos            .004 | 
 30. |            Terbufos             .85 | 
     |-------------------------------------| 
 31. |   Tetrachlorvinphos            .001 | 
 32. |            Tribufos             .02 | 
 33. |         Trichlorfon            .003 | 
     +-------------------------------------+ 
 
.  
. //      Save temporary file. 
.         tempfile myFile 
 
.         save `myFile', replace 
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(note: file C:\Users\au231481\AppData\Local\Temp\ST_3ea0_000001.tmp not found) 
file C:\Users\au231481\AppData\Local\Temp\ST_3ea0_000001.tmp saved 
 
.          
. //      Open table of RBC ChE potency from USEPA 2002. List the data. 
.         import excel using "rbc_che_potency_USEPA_2002.xlsx", firstrow clear 
 
.         de,f 
 
Contains data 
  obs:            49                           
 vars:             6                           
 size:         2,107                           
--------------------------------------------------------------------------------------------------------- 
              storage   display    value 
variable name   type    format     label      variable label 
--------------------------------------------------------------------------------------------------------- 
chemical        str17   %17s                  chemical 
sex             str1    %9s                   sex 
n               byte    %10.0g                n 
potency_rbc     double  %10.0g                potency_rbc 
potency_rbc_ll  double  %10.0g                potency_rbc_ll 
potency_rbc_ul  double  %10.0g                potency_rbc_ul 
--------------------------------------------------------------------------------------------------------- 
Sorted by:  
     Note: Dataset has changed since last saved. 
 
.  
.         label variable potency_rbc "Relative potency, RBC" 
 
.         label variable potency_rbc_ll "Relative potency, RBC (lower limit of 95% CI)" 
 
.         label variable potency_rbc_ul "Relative potency, RBC (upper limit of 95% CI)" 
 
.         label variable n "Number of data points" 
 
.          
.         sort chemical sex 
 
.         list, ab(32) 
 
     +------------------------------------------------------------------------------+ 
     |          chemical   sex    n   potency_rbc   potency_rbc_ll   potency_rbc_ul | 
     |------------------------------------------------------------------------------| 
  1. |          Acephate     F   15         .0216           .00906            .0517 | 
  2. |          Acephate     M   15         .0207            .0094            .0455 | 
  3. |   Azinphos-methyl     F    8          .349             .148             .821 | 
  4. |   Azinphos-methyl     M    8          .351             .199             .619 | 
  5. |         Bensulide     F    5         .0113           .00974            .0132 | 
     |------------------------------------------------------------------------------| 
  6. |      Chlorpyrifos     F    9         .0894            .0153              .52 | 
  7. |      Chlorpyrifos     M    9          .102            .0511             .206 | 
  8. |          Diazinon     F   12          .269             .103             .703 | 
  9. |          Diazinon     M   12          .145             .036             .585 | 
 10. |        Dichlorvos     F    7           .23              .07              .78 | 
     |------------------------------------------------------------------------------| 
 11. |        Dichlorvos     M    6           .14               .1              .21 | 
 12. |        Dimethoate     F    9          .392             .203             .757 | 
 13. |        Dimethoate     M    9          .431             .278             .666 | 
 14. |        Disulfoton     F   10          4.87             4.43             5.36 | 
 15. |        Disulfoton     M   10          3.55             2.94             4.28 | 
     |------------------------------------------------------------------------------| 
 16. |        Fenamiphos     F    9          .753               .6              .95 | 
 17. |        Fenamiphos     M    8           .56              .44              .72 | 
 18. |       Fosthiazate     F   12          .432             .311               .6 | 
 19. |       Fosthiazate     M   10          .265             .122             .579 | 
 20. |         Malathion     F    7         .0041           .00312           .00539 | 
     |------------------------------------------------------------------------------| 
 21. |         Malathion     M    7        .00424           .00293           .00613 | 
 22. |     Methamidophos     F   10             1               .7             1.44 | 
 23. |     Methamidophos     M   10          1.23              .82             1.83 | 
 24. |      Methidathion     F    8           .29              .05             1.63 | 
 25. |      Methidathion     M    7           .25              .05             1.14 | 
     |------------------------------------------------------------------------------| 
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 26. |  Methyl-parathion     F   10          .249            .0607             1.02 | 
 27. |  Methyl-parathion     M   10          .303            .0525             1.75 | 
 28. |         Mevinphos     F    5          .602            .0988             3.67 | 
 29. |         Mevinphos     M    5           .46            .0527             4.01 | 
 30. |             Naled     F    5           .05            .0263             .113 | 
     |------------------------------------------------------------------------------| 
 31. |             Naled     M    5           .03            .0235            .0449 | 
 32. | Oxydemeton-methyl     F    9          .448             .251               .8 | 
 33. | Oxydemeton-methyl     M   15          .994              .51             1.94 | 
 34. |           Phorate     F    5          4.49             3.88              5.2 | 
 35. |           Phorate     M    5          3.02             2.69             3.39 | 
     |------------------------------------------------------------------------------| 
 36. |         Phosalone     F    8           .05              .02              .14 | 
 37. |         Phosalone     M    7           .09              .04               .2 | 
 38. |           Phosmet     F    7           .14              .12              .18 | 
 39. |           Phosmet     M    7           .12               .1              .15 | 
 40. | Pirimiphos-methyl     F   16          .034            .0244            .0475 | 
     |------------------------------------------------------------------------------| 
 41. | Pirimiphos-methyl     M   16         .0319             .025            .0407 | 
 42. |          Terbufos     F   17          2.01              .45             8.94 | 
 43. |          Terbufos     M   17          3.79             1.17             12.3 | 
 44. | Tetrachlorvinphos     F    6        .00534           .00152            .0188 | 
 45. | Tetrachlorvinphos     M    2        .00246          .000979           .00616 | 
     |------------------------------------------------------------------------------| 
 46. |          Tribufos     F    6           .18              .09              .34 | 
 47. |          Tribufos     M    6           .28              .19              .42 | 
 48. |       Trichlorfon     F    7        .00457           .00216           .00967 | 
 49. |       Trichlorfon     M    5        .00479           .00259           .00884 | 
     +------------------------------------------------------------------------------+ 
 
.          
. /*      We note that for Bensulide we only have data points for female rats. The USEPA 2002 publication 
>         does not list numerical results for Bensulide for male rats (I don't want to try and read value 
> s 
>         from a graph with a logarithmic axis).  */ 
.          
. /*      Perform fixed-effect meta-analysis using inverse variance weights to get common (rather than 
>         gender-specific) estimates.     */ 
.         gen log_est = log(potency_rbc) 
 
.         gen log_ll = log(potency_rbc_ll) 
 
.         gen log_ul = log(potency_rbc_ul) 
 
.         gen log_se = (log_ul - log_ll) / (2 * 1.96) 
 
.         gen log_sd = log_se * sqrt(n) 
 
.         gen log_variance = log_sd^2 
 
.         gen w = 1/log_variance 
 
.         gen weighted_log_est = w * log_est 
 
.         collapse (sum) weighted_log_est w, by(chemical) 
 
.         gen log_est = weighted_log_est / w 
 
.         gen potency_rbc = exp(log_est) 
 
.         keep chemical potency_rbc 
 
.         label variable potency_rbc "Relative potency, RBC" 
 
.         list, ab(32) 
 
     +---------------------------------+ 
     |          chemical   potency_rbc | 
     |---------------------------------| 
  1. |          Acephate      .0211007 | 
  2. |   Azinphos-methyl       .350389 | 
  3. |         Bensulide         .0113 | 
  4. |      Chlorpyrifos      .1001979 | 
  5. |          Diazinon      .2204856 | 
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     |---------------------------------| 
  6. |        Dichlorvos      .1453171 | 
  7. |        Dimethoate      .4186764 | 
  8. |        Disulfoton      4.564723 | 
  9. |        Fenamiphos      .6503644 | 
 10. |       Fosthiazate      .3963854 | 
     |---------------------------------| 
 11. |         Malathion      .0041491 | 
 12. |     Methamidophos      1.096886 | 
 13. |      Methidathion      .2658181 | 
 14. |  Methyl-parathion      .2689685 | 
 15. |         Mevinphos      .5390574 | 
     |---------------------------------| 
 16. |             Naled      .0326339 | 
 17. | Oxydemeton-methyl      .5740668 | 
 18. |           Phorate      3.517057 | 
 19. |         Phosalone      .0722202 | 
 20. |           Phosmet      .1296148 | 
     |---------------------------------| 
 21. | Pirimiphos-methyl       .032617 | 
 22. |          Terbufos      2.973561 | 
 23. | Tetrachlorvinphos      .0027661 | 
 24. |          Tribufos      .2493234 | 
 25. |       Trichlorfon      .0047176 | 
     +---------------------------------+ 
 
.          
. //      Merge the two files 
.         merge 1:1 chemical using `myFile' 
(note: variable chemical was str17, now str19 to accommodate using data's values) 
 
    Result                           # of obs. 
    ----------------------------------------- 
    not matched                             8 
        from master                         0  (_merge==1) 
        from using                          8  (_merge==2) 
 
    matched                                25  (_merge==3) 
    ----------------------------------------- 
 
.         sort _merge 
 
.         drop _merge 
 
.          
. //      There are eight compounds for which we have potency data for brain, but not RBC 
.         list, ab(32) 
 
     +---------------------------------------------------+ 
     |            chemical   potency_rbc   potency_brain | 
     |---------------------------------------------------| 
  1. |          Profenofos             .            .004 | 
  2. |       Phostebupirim             .             .22 | 
  3. |           Omethoate             .             .93 | 
  4. |            Fenthion             .             .33 | 
  5. |            Ethoprop             .             .06 | 
     |---------------------------------------------------| 
  6. |         Dicrotophos             .            1.91 | 
  7. | Chlorpyrifos-methyl             .            .005 | 
  8. |      Chlorethoxyfos             .             .13 | 
  9. |         Trichlorfon      .0047176            .003 | 
 10. |            Tribufos      .2493234             .02 | 
     |---------------------------------------------------| 
 11. |   Tetrachlorvinphos      .0027661            .001 | 
 12. |            Terbufos      2.973561             .85 | 
 13. |   Pirimiphos-methyl       .032617             .04 | 
 14. |             Phosmet      .1296148             .02 | 
 15. |           Phosalone      .0722202             .01 | 
     |---------------------------------------------------| 
 16. |             Phorate      3.517057             .39 | 
 17. |   Oxydemeton-methyl      .5740668             .86 | 
 18. |               Naled      .0326339             .08 | 
 19. |           Mevinphos      .5390574             .76 | 
 20. |    Methyl-parathion      .2689685             .12 | 
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     |---------------------------------------------------| 
 21. |        Methidathion      .2658181             .32 | 
 22. |       Methamidophos      1.096886               1 | 
 23. |           Malathion      .0041491           .0003 | 
 24. |         Fosthiazate      .3963854             .07 | 
 25. |          Fenamiphos      .6503644             .04 | 
     |---------------------------------------------------| 
 26. |          Disulfoton      4.564723            1.26 | 
 27. |          Dimethoate      .4186764             .32 | 
 28. |          Dichlorvos      .1453171             .03 | 
 29. |            Diazinon      .2204856             .01 | 
 30. |        Chlorpyrifos      .1001979             .06 | 
     |---------------------------------------------------| 
 31. |           Bensulide         .0113            .003 | 
 32. |     Azinphos-methyl       .350389              .1 | 
 33. |            Acephate      .0211007             .08 | 
     +---------------------------------------------------+ 
 
.          
. //      Generate a variable equal to the ratio between the brain and the RBC potencies 
.         gen ratio = potency_brain / potency_rbc 
(8 missing values generated) 
 
.         label variable ratio "Ratio of potencies (brain/RBC)" 
 
.          
. //      Save temporary file 
.         save `myFile', replace 
file C:\Users\au231481\AppData\Local\Temp\ST_3ea0_000001.tmp saved 
 
.          
. //      Add data on physicochemical properties of organophosphates from PubChem. 
.         import delimited using "pubchem_data.csv", clear encoding("utf-8") 
(6 vars, 33 obs) 
 
.         label variable molecularweight "Molecular weight (g/mol)" 
 
.         label variable tpsa "Topological polar surface area (Å{sup:2})" 
 
.         label variable xlogp "XLogP" 
 
.         label variable hbonddonorcount "Hydrogen bond donor count" 
 
.         de,f 
 
Contains data 
  obs:            33                           
 vars:             6                           
 size:         1,188                           
--------------------------------------------------------------------------------------------------------- 
              storage   display    value 
variable name   type    format     label      variable label 
--------------------------------------------------------------------------------------------------------- 
chemical        str19   %19s                   
pubchem_id      long    %12.0g                 
molecularweight float   %9.0g                 Molecular weight (g/mol) 
tpsa            float   %9.0g                 Topological polar surface area (Å{sup:2}) 
xlogp           float   %9.0g                 XLogP 
hbonddonorcount byte    %8.0g                 Hydrogen bond donor count 
--------------------------------------------------------------------------------------------------------- 
Sorted by:  
     Note: Dataset has changed since last saved. 
 
.          
.         list, ab(32) 
 
     +-------------------------------------------------------------------------------------+ 
     |            chemical   pubchem_id   molecularweight   tpsa   xlogp   hbonddonorcount | 
     |-------------------------------------------------------------------------------------| 
  1. |            Acephate         1982            183.17   80.7     -.8                 1 | 
  2. |     Azinphos-methyl         2268             317.3    121     2.8                 0 | 
  3. |           Bensulide        12932             397.5    130     4.2                 1 | 
  4. |      Chlorethoxyfos        91655               336   59.8     4.6                 0 | 
  5. |        Chlorpyrifos         2730             350.6   72.7     5.3                 0 | 
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     |-------------------------------------------------------------------------------------| 
  6. | Chlorpyrifos-methyl        21803             322.5   72.7     4.3                 0 | 
  7. |            Diazinon         3017            304.35   85.6     3.8                 0 | 
  8. |          Dichlorvos         3039            220.97   44.8     1.4                 0 | 
  9. |         Dicrotophos      5371560            237.19   65.1       0                 0 | 
 10. |          Dimethoate         3082             229.3    105      .8                 1 | 
     |-------------------------------------------------------------------------------------| 
 11. |          Disulfoton         3118             274.4    101       4                 0 | 
 12. |            Ethoprop         3289             242.3   76.9     3.6                 0 | 
 13. |          Fenamiphos        31070            303.36   72.9     3.2                 1 | 
 14. |            Fenthion         3346             278.3   85.1     4.1                 0 | 
 15. |         Fosthiazate        91758             283.4   97.2       2                 0 | 
     |-------------------------------------------------------------------------------------| 
 16. |           Malathion         4004             330.4    128     2.4                 0 | 
 17. |       Methamidophos         4096            141.13   77.6     -.9                 1 | 
 18. |        Methidathion        13709             302.3    143     2.4                 0 | 
 19. |    Methyl-parathion         4130            263.21    106     2.9                 0 | 
 20. |           Mevinphos      5355863            224.15   71.1     1.2                 0 | 
     |-------------------------------------------------------------------------------------| 
 21. |               Naled         4420            380.78   44.8     2.5                 0 | 
 22. |           Omethoate        14210            213.19   89.9     -.9                 1 | 
 23. |   Oxydemeton-methyl         4618             246.3   97.1     -.7                 0 | 
 24. |             Phorate         4790             260.4    101     3.6                 0 | 
 25. |           Phosalone         4793             367.8    105     4.4                 0 | 
     |-------------------------------------------------------------------------------------| 
 26. |             Phosmet        12901             317.3    113     2.8                 0 | 
 27. |       Phostebupirim        93516            318.37   85.6     4.2                 0 | 
 28. |   Pirimiphos-methyl        34526            305.34   88.8     4.2                 0 | 
 29. |          Profenofos        38779            373.63   60.8     4.7                 0 | 
 30. |            Terbufos        25670             288.4    101     4.5                 0 | 
     |-------------------------------------------------------------------------------------| 
 31. |   Tetrachlorvinphos      5284462               366   44.8     3.5                 0 | 
 32. |            Tribufos         5125             314.5     93     3.2                 0 | 
 33. |         Trichlorfon         5853            257.43   55.8      .5                 1 | 
     +-------------------------------------------------------------------------------------+ 
 
.          
. /*      These properties were selected as a priori candidates for the relationship between brain and 
>         RBC potency for OP insecticides. The choice was made based on the following article that 
>         describes determinants of whether a compound can cross the blood-brain barrier: 
>          
>         Geldenhuys, Werner J., et al. "Molecular determinants of blood-brain barrier permeation" 
>         Therapeutic delivery 6.8 (2015): 961-971. DOI: 10.4155/tde.15.32 
>          
>         The article also mentions pKa as an important property, but that was deemed irrelevant based 
>         on the structure of the compounds. 
>         */ 
.          
. //      Merge with the main dataset 
.         merge 1:1 chemical using `myFile', nogen 
 
    Result                           # of obs. 
    ----------------------------------------- 
    not matched                             0 
    matched                                33   
    ----------------------------------------- 
 
.          
. //      Summarize the physicochemical properties 
.         su molecularweight tpsa xlogp 
 
    Variable |        Obs        Mean    Std. Dev.       Min        Max 
-------------+--------------------------------------------------------- 
molecularw~t |         33    289.4324     59.4423     141.13      397.5 
        tpsa |         33    87.17576    24.79146       44.8        143 
       xlogp |         33    2.660606    1.833361        -.9        5.3 
 
.         tab hbonddonorcount, missing 
 
   Hydrogen | 
 bond donor | 
      count |      Freq.     Percent        Cum. 
------------+----------------------------------- 
          0 |         26       78.79       78.79 
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          1 |          7       21.21      100.00 
------------+----------------------------------- 
      Total |         33      100.00 
 
.          
. /*      We notice how we have too little data to meaningfully include the number of hydrogen bond donor 
> s 
>         in any models. We will therefore ignore the variable hbonddonorcount from now on.       */ 
.          
. /*      Draw scatterplots of each of the three continuous properties vs. the ratio of potencies. These 
>         graphs will help us determine the best modelling strategy.      */ 
.         graph drop _all 
 
.         foreach v of var molecularweight tpsa xlogp { 
  2.                 local title: variable label `v' 
  3.                 twoway scatter ratio `v', title("Ratio vs. `title'") xsize(11.7) ysize(8.3) 
  4.                 graph export Graphs/ratio_vs_`v'.pdf, replace 
  5.                 } 
(file Graphs/ratio_vs_molecularweight.pdf written in PDF format) 
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(file Graphs/ratio_vs_tpsa.pdf written in PDF format) 
 
(file Graphs/ratio_vs_xlogp.pdf written in PDF format) 
 
 
.         graph drop _all 
 
.          
. /*      For each of the three potential explanatory variables, do a regression with 'ratio' as the 
>         dependent variable.     */ 
.         foreach v of var molecularweight tpsa xlogp { 
  2.                 local title: variable label `v' 
  3.                 disp _n(2) "Ratio vs. `title'" 
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  4.                 regress ratio `v' 
  5.                 } 
 
 
Ratio vs. Molecular weight (g/mol) 
 
      Source |       SS           df       MS      Number of obs   =        25 
-------------+----------------------------------   F(1, 23)        =      2.57 
       Model |  1.84619638         1  1.84619638   Prob > F        =    0.1223 
    Residual |  16.4957038        23  .717204511   R-squared       =    0.1007 
-------------+----------------------------------   Adj R-squared   =    0.0616 
       Total |  18.3419001        24  .764245839   Root MSE        =    .84688 
 
--------------------------------------------------------------------------------- 
          ratio |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
----------------+---------------------------------------------------------------- 
molecularweight |  -.0045044   .0028075    -1.60   0.122    -.0103122    .0013034 
          _cons |   2.000971   .8293902     2.41   0.024     .2852463    3.716695 
--------------------------------------------------------------------------------- 
 
 
Ratio vs. Topological polar surface area (Å{sup:2}) 
 
      Source |       SS           df       MS      Number of obs   =        25 
-------------+----------------------------------   F(1, 23)        =      1.46 
       Model |  1.09322796         1  1.09322796   Prob > F        =    0.2396 
    Residual |  17.2486722        23  .749942269   R-squared       =    0.0596 
-------------+----------------------------------   Adj R-squared   =    0.0187 
       Total |  18.3419001        24  .764245839   Root MSE        =    .86599 
 
------------------------------------------------------------------------------ 
       ratio |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
        tpsa |  -.0080207   .0066431    -1.21   0.240    -.0217629    .0057216 
       _cons |   1.430099   .6303487     2.27   0.033     .1261236    2.734075 
------------------------------------------------------------------------------ 
 
 
Ratio vs. XLogP 
 
      Source |       SS           df       MS      Number of obs   =        25 
-------------+----------------------------------   F(1, 23)        =      9.17 
       Model |  5.22938199         1  5.22938199   Prob > F        =    0.0060 
    Residual |  13.1125182        23  .570109485   R-squared       =    0.2851 
-------------+----------------------------------   Adj R-squared   =    0.2540 
       Total |  18.3419001        24  .764245839   Root MSE        =    .75506 
 
------------------------------------------------------------------------------ 
       ratio |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
       xlogp |  -.2705725   .0893383    -3.03   0.006    -.4553828   -.0857622 
       _cons |   1.382333   .2716824     5.09   0.000     .8203153    1.944351 
------------------------------------------------------------------------------ 
 
.                  
. /*      Based on the adjusted R^2, XLogP is clearly the best predictor of the ratio between brain and 
>         RBC potencies. We try to fit two new models of the ratio, each using XLogP and another 
>         variable as predictors. */ 
.         foreach v of var molecularweight tpsa { 
  2.                 local title: variable label `v' 
  3.                 disp _n(2) "Ratio vs. `title' (in addition to xlogp)" 
  4.                 regress ratio xlogp `v' 
  5.                 } 
 
 
Ratio vs. Molecular weight (g/mol) (in addition to xlogp) 
 
      Source |       SS           df       MS      Number of obs   =        25 
-------------+----------------------------------   F(2, 22)        =      4.76 
       Model |  5.53651052         2  2.76825526   Prob > F        =    0.0192 
    Residual |  12.8053896        22  .582063164   R-squared       =    0.3019 
-------------+----------------------------------   Adj R-squared   =    0.2384 
       Total |  18.3419001        24  .764245839   Root MSE        =    .76293 
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--------------------------------------------------------------------------------- 
          ratio |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
----------------+---------------------------------------------------------------- 
          xlogp |  -.3457251   .1373044    -2.52   0.020     -.630477   -.0609733 
molecularweight |   .0027945    .003847     0.73   0.475    -.0051838    .0107728 
          _cons |   .7641765   .8941699     0.85   0.402    -1.090218    2.618571 
--------------------------------------------------------------------------------- 
 
 
Ratio vs. Topological polar surface area (Å{sup:2}) (in addition to xlogp) 
 
      Source |       SS           df       MS      Number of obs   =        25 
-------------+----------------------------------   F(2, 22)        =      4.85 
       Model |  5.60971898         2  2.80485949   Prob > F        =    0.0180 
    Residual |  12.7321812        22  .578735508   R-squared       =    0.3058 
-------------+----------------------------------   Adj R-squared   =    0.2427 
       Total |  18.3419001        24  .764245839   Root MSE        =    .76075 
 
------------------------------------------------------------------------------ 
       ratio |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
       xlogp |  -.2562514   .0917288    -2.79   0.011    -.4464852   -.0660175 
        tpsa |  -.0048211   .0059471    -0.81   0.426    -.0171545    .0075123 
       _cons |   1.785987   .5682069     3.14   0.005     .6075984    2.964376 
------------------------------------------------------------------------------ 
 
.          
. /*      Based on the adjusted R^2 in these analyses, it is clear that we might as well stick with a 
>         model where the only independent variable is xlogp. We fit this model again, and we draw 
>         diagnostic plots to make sure that model assumptions are fulfilled.     */ 
.         local title: variable label xlogp 
 
.         disp _n(2) "Ratio vs. `title'" 
 
 
Ratio vs. XLogP 
 
.         regress ratio xlogp 
 
      Source |       SS           df       MS      Number of obs   =        25 
-------------+----------------------------------   F(1, 23)        =      9.17 
       Model |  5.22938199         1  5.22938199   Prob > F        =    0.0060 
    Residual |  13.1125182        23  .570109485   R-squared       =    0.2851 
-------------+----------------------------------   Adj R-squared   =    0.2540 
       Total |  18.3419001        24  .764245839   Root MSE        =    .75506 
 
------------------------------------------------------------------------------ 
       ratio |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
       xlogp |  -.2705725   .0893383    -3.03   0.006    -.4553828   -.0857622 
       _cons |   1.382333   .2716824     5.09   0.000     .8203153    1.944351 
------------------------------------------------------------------------------ 
 
.         predict residual if e(sample), res 
(8 missing values generated) 
 
.         graph drop _all 
 
.         scatter residual xlogp, title("Residuals vs. `title'") name(g1) 
 
.         histogram residual, normal width(0.5) title("Histogram of residuals") name(g2) 
(bin=6, start=-.7970866, width=.5) 
 
.         qnorm residual, title("QQ-plot of residuals") name(g3) 
 
.         scatter ratio xlogp, title("Simple scatterplot") name(g4) 
 
.         graph combine g1 g2 g3 g4, cols(2) title("Ratio vs. `title'") subtitle("Diagnostic plots")      
>  /// 
>                 xsize(11.7) ysize(8.3) 
 
.         graph export Graphs/ratio_vs_xlogp_diagnostics.pdf, replace 
(file Graphs/ratio_vs_xlogp_diagnostics.pdf written in PDF format) 
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.         graph drop _all 
 
.         drop residual 
 
.          
. /*      Unfortunately, it is clear from the diagnostic plots that the model does not hold. Residuals ar 
> e 
>         right-skewed (they should be normally distributed), and when comparing high and low values 
>         of xlogp, the residuals show a funnel shape.    */ 
.  
. /*      The problem can be solved by performing "a multiplicative heteroskedastic linear regression by 
>         modeling the variance as an exponential function of" the explanatory variable (wording between 
>         quotes from Stata help file).   */ 
.         hetregress ratio xlogp, het(xlogp) 
 
Fitting full model: 
 
Iteration 0:   log likelihood =  -23.82729   
Iteration 1:   log likelihood = -23.700717   
Iteration 2:   log likelihood = -23.700448   
Iteration 3:   log likelihood = -23.700448   
 
Heteroskedastic linear regression               Number of obs     =         25 
ML estimation 
                                                Wald chi2(1)      =       1.35 
Log likelihood = -23.70045                      Prob > chi2       =     0.2449 
 
------------------------------------------------------------------------------ 
       ratio |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
ratio        | 
       xlogp |  -.1269779   .1091968    -1.16   0.245    -.3409996    .0870439 
       _cons |   .9311111   .4070543     2.29   0.022     .1332993    1.728923 
-------------+---------------------------------------------------------------- 
lnsigma2     | 
       xlogp |  -.5089955   .2096058    -2.43   0.015    -.9198153   -.0981757 
       _cons |   .3448994   .6006467     0.57   0.566    -.8323465    1.522145 
------------------------------------------------------------------------------ 
LR test of lnsigma2=0: chi2(1) = 7.41                     Prob > chi2 = 0.0065 
 
.  
. /*      Make predictions based on the heteroskedastic linear regression. Then plot the predictions, 
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>         along with the actual data behind the model.    */ 
.         gen sampled = 1 if e(sample) 
(8 missing values generated) 
 
.         predict ratio_predicted if sampled == 1, xb 
(8 missing values generated) 
 
.         predict se_ratio_predicted if sampled == 1, stdp 
 
.         gen ul_ci_ratio_predicted = ratio_predicted + 1.96 * se_ratio_predicted 
(8 missing values generated) 
 
.         gen ll_ci_ratio_predicted = ratio_predicted - 1.96 * se_ratio_predicted 
(8 missing values generated) 
 
.  
.         sort ratio_predicted 
 
.         local ytitle: variable label ratio 
 
.         twoway                                                                                          
>                                                                                  /// 
>                 (scatter ratio xlogp)                                                                   
>                                                                  /// 
>                 (line ratio_predicted xlogp, lpattern(solid) lcolor(black))                             
>                                  /// 
>                 (line ul_ci_ratio_predicted xlogp, lpattern(dash) lcolor(black))                        
>                          /// 
>                 (line ll_ci_ratio_predicted xlogp, lpattern(dash) lcolor(black))                        
>                          /// 
>                 , legend(off) title("Ratio vs. `title'") subtitle("Heteroskedastic linear model")       
>          /// 
>                 ytitle("`ytitle'") 
 
.         graph export Graphs/ratio_vs_xlogp_heteroskedastic_diagnostics.pdf, replace 
(file Graphs/ratio_vs_xlogp_heteroskedastic_diagnostics.pdf written in PDF format) 
 
 
.         graph drop _all 
 
.         drop *predicted* sampled 
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.          
. /*      The heteroskedastic model is a better description of the data, but we still have a problem: 
>         when XLogP become large, the predicted ratio can become negative, which is meaningless, as the 
>         potency of a compound in both brain and RBC must be positive. We therefore have to try another 
>         modelling strategy. We log-transfor the ratio of the potencies as use the transformed ratio as 
>         the dependent variable in a linear regression model. Modelling the relationship in this way 
>         insures that the ratio will always be positive (on the original scale), as as we will see, it 
>         also fits the data.     */ 
.          
.         local ratioLabel: variable label ratio 
 
.         gen log_ratio = log(ratio) 
(8 missing values generated) 
 
.         label variable log_ratio "log(`ratioLabel')" 
 
.  
. /*      Draw scatterplots of each of the three continuous properties vs. the log(ratio of potencies). 
>         These graphs will help us determine the best modelling strategy.        */ 
.         graph drop _all 
 
.         foreach v of var molecularweight tpsa xlogp { 
  2.                 local title: variable label `v' 
  3.                 twoway scatter log_ratio `v', title("log(ratio) vs. `title'") xsize(11.7) ysize(8.3) 
  4.                 graph export Graphs/log_ratio_vs_`v'.pdf, replace 
  5.                 } 
(file Graphs/log_ratio_vs_molecularweight.pdf written in PDF format) 
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(file Graphs/log_ratio_vs_tpsa.pdf written in PDF format) 
 
 
(file Graphs/log_ratio_vs_xlogp.pdf written in PDF format) 
 
 
.         graph drop _all  
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.          
. /*      Showing that also the log-transformed ratio is best predicted based on a model with xlogp as th 
> e 
>         only explanatory variable.      */ 
.         foreach v of var molecularweight tpsa xlogp { 
  2.                 local title: variable label `v' 
  3.                 disp _n(2) "log(ratio) vs. `title'" 
  4.                 regress log_ratio `v' 
  5.                 } 
 
 
log(ratio) vs. Molecular weight (g/mol) 
 
      Source |       SS           df       MS      Number of obs   =        25 
-------------+----------------------------------   F(1, 23)        =      2.78 
       Model |  3.72169112         1  3.72169112   Prob > F        =    0.1089 
    Residual |  30.7628127        23  1.33751359   R-squared       =    0.1079 
-------------+----------------------------------   Adj R-squared   =    0.0691 
       Total |  34.4845038        24  1.43685432   Root MSE        =    1.1565 
 
--------------------------------------------------------------------------------- 
      log_ratio |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
----------------+---------------------------------------------------------------- 
molecularweight |  -.0063955    .003834    -1.67   0.109    -.0143267    .0015357 
          _cons |   .8377997   1.132626     0.74   0.467    -1.505215    3.180815 
--------------------------------------------------------------------------------- 
 
 
log(ratio) vs. Topological polar surface area (Å{sup:2}) 
 
      Source |       SS           df       MS      Number of obs   =        25 
-------------+----------------------------------   F(1, 23)        =      1.12 
       Model |  1.60406701         1  1.60406701   Prob > F        =    0.3005 
    Residual |  32.8804368        23  1.42958421   R-squared       =    0.0465 
-------------+----------------------------------   Adj R-squared   =    0.0051 
       Total |  34.4845038        24  1.43685432   Root MSE        =    1.1957 
 
------------------------------------------------------------------------------ 
   log_ratio |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
        tpsa |  -.0097155   .0091719    -1.06   0.300    -.0286891     .009258 
       _cons |  -.1253069   .8703057    -0.14   0.887    -1.925671    1.675058 
------------------------------------------------------------------------------ 
 
 
log(ratio) vs. XLogP 
 
      Source |       SS           df       MS      Number of obs   =        25 
-------------+----------------------------------   F(1, 23)        =      7.72 
       Model |  8.66425769         1  8.66425769   Prob > F        =    0.0107 
    Residual |  25.8202461        23   1.1226194   R-squared       =    0.2513 
-------------+----------------------------------   Adj R-squared   =    0.2187 
       Total |  34.4845038        24  1.43685432   Root MSE        =    1.0595 
 
------------------------------------------------------------------------------ 
   log_ratio |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
       xlogp |  -.3482765   .1253645    -2.78   0.011    -.6076128   -.0889402 
       _cons |  -.1312697   .3812402    -0.34   0.734     -.919925    .6573857 
------------------------------------------------------------------------------ 
 
.         foreach v of var molecularweight tpsa { 
  2.                 local title: variable label `v' 
  3.                 disp _n(2) "log(ratio) vs. `title' (in addition to xlogp)" 
  4.                 regress log_ratio xlogp `v' 
  5.                 } 
 
 
log(ratio) vs. Molecular weight (g/mol) (in addition to xlogp) 
 
      Source |       SS           df       MS      Number of obs   =        25 
-------------+----------------------------------   F(2, 22)        =      3.80 
       Model |  8.85718899         2  4.42859449   Prob > F        =    0.0382 
    Residual |  25.6273148        22  1.16487795   R-squared       =    0.2568 
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-------------+----------------------------------   Adj R-squared   =    0.1893 
       Total |  34.4845038        24  1.43685432   Root MSE        =    1.0793 
 
--------------------------------------------------------------------------------- 
      log_ratio |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
----------------+---------------------------------------------------------------- 
          xlogp |  -.4078407   .1942404    -2.10   0.047    -.8106706   -.0050108 
molecularweight |   .0022148   .0054423     0.41   0.688    -.0090718    .0135015 
          _cons |  -.6212062   1.264955    -0.49   0.628    -3.244563    2.002151 
--------------------------------------------------------------------------------- 
 
 
log(ratio) vs. Topological polar surface area (Å{sup:2}) (in addition to xlogp) 
 
      Source |       SS           df       MS      Number of obs   =        25 
-------------+----------------------------------   F(2, 22)        =      3.99 
       Model |  9.17260067         2  4.58630033   Prob > F        =    0.0333 
    Residual |  25.3119031        22  1.15054105   R-squared       =    0.2660 
-------------+----------------------------------   Adj R-squared   =    0.1993 
       Total |  34.4845038        24  1.43685432   Root MSE        =    1.0726 
 
------------------------------------------------------------------------------ 
   log_ratio |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
       xlogp |  -.3317199   .1293352    -2.56   0.018    -.5999446   -.0634951 
        tpsa |  -.0055737   .0083852    -0.66   0.513    -.0229635    .0118162 
       _cons |   .3353938   .8011568     0.42   0.680    -1.326104    1.996891 
------------------------------------------------------------------------------ 
 
.                  
. /*      Based on the adjusted R^2 in these analyses, it is clear that we might as well stick with a 
>         model where the only independent variable is xlogp. We fit this model again, and we draw 
>         diagnostic plots to make sure that model assumptions are fulfilled.     */ 
.         local title: variable label xlogp 
 
.         disp _n(2) "log(ratio) vs. `title'" 
 
 
log(ratio) vs. XLogP 
 
.         regress log_ratio xlogp 
 
      Source |       SS           df       MS      Number of obs   =        25 
-------------+----------------------------------   F(1, 23)        =      7.72 
       Model |  8.66425769         1  8.66425769   Prob > F        =    0.0107 
    Residual |  25.8202461        23   1.1226194   R-squared       =    0.2513 
-------------+----------------------------------   Adj R-squared   =    0.2187 
       Total |  34.4845038        24  1.43685432   Root MSE        =    1.0595 
 
------------------------------------------------------------------------------ 
   log_ratio |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
       xlogp |  -.3482765   .1253645    -2.78   0.011    -.6076128   -.0889402 
       _cons |  -.1312697   .3812402    -0.34   0.734     -.919925    .6573857 
------------------------------------------------------------------------------ 
 
.         gen sampled = 1 if e(sample) 
(8 missing values generated) 
 
.         predict residual if sampled == 1, res 
(8 missing values generated) 
 
.         predict log_ratio_predicted, xb 
 
.         predict se_log_ratio_predicted if sampled == 1, stdf 
(8 missing values generated) 
 
.         gen ul_ci_predicted = log_ratio_predicted + 1.96 * se_log_ratio_predicted 
(8 missing values generated) 
 
.         gen ll_ci_predicted = log_ratio_predicted - 1.96 * se_log_ratio_predicted 
(8 missing values generated) 
 
.         graph drop _all 
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.         scatter residual xlogp, title("Residuals vs. `title'") name(g1) 
 
.         histogram residual, normal width(0.5) title("Histogram of residuals") name(g2) 
(bin=8, start=-1.6597197, width=.5) 
 
.         qnorm residual, title("QQ-plot of residuals") name(g3) 
 
.         twoway                                                                                          
>                                                                                  /// 
>                 (scatter log_ratio xlogp)                                                               
>                                                                  /// 
>                 (line log_ratio_predicted xlogp, lpattern(solid) lcolor(black))                         
>                          /// 
>                 (line ll_ci_predicted xlogp, lpattern(dash) lcolor(black))                              
>                                  /// 
>                 (line ul_ci_predicted xlogp, lpattern(dash) lcolor(black))                              
>                                  /// 
>                 , title("Scatterplot with fitted line") subtitle("and 95% CI")                          
>                          /// 
>                 legend(off) name(g4) ytitle("log(ratio)") 
 
.         graph combine g1 g2 g3 g4, cols(2) title("log(ratio) vs. `title'")                              
>                          /// 
>                 subtitle("Diagnostic plots") xsize(11.7) ysize(8.3) 
 
.         graph export Graphs/log_ratio_vs_xlogp_diagnostics.pdf, replace 
 
(file Graphs/log_ratio_vs_xlogp_diagnostics.pdf written in PDF format) 
 
 
.         graph drop _all 
 
.         drop residual 
 
.          
. //      Prettify dataset. 
.         replace log_ratio = log_ratio_predicted if sampled != 1 
(8 real changes made) 
 
.         replace ratio = exp(log_ratio) if sampled != 1 
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(8 real changes made) 
 
.         replace potency_rbc = potency_brain/ratio if sampled != 1 
(8 real changes made) 
 
.         recode sampled (1 = 1 "Original") (. = 0 "Predicted"), gen(rbc_group) 
(8 differences between sampled and rbc_group) 
 
.         keep chemical potency* rbc_group 
 
.         format %15.3f potency* 
 
.          
. //      List dataset 
.         sort chemical 
 
.         list, ab(32) 
 
     +---------------------------------------------------------------+ 
     |            chemical   potency_rbc   potency_brain   rbc_group | 
     |---------------------------------------------------------------| 
  1. |            Acephate         0.021           0.080    Original | 
  2. |     Azinphos-methyl         0.350           0.100    Original | 
  3. |           Bensulide         0.011           0.003    Original | 
  4. |      Chlorethoxyfos         0.736           0.130   Predicted | 
  5. |        Chlorpyrifos         0.100           0.060    Original | 
     |---------------------------------------------------------------| 
  6. | Chlorpyrifos-methyl         0.025           0.005   Predicted | 
  7. |            Diazinon         0.220           0.010    Original | 
  8. |          Dichlorvos         0.145           0.030    Original | 
  9. |         Dicrotophos         2.178           1.910   Predicted | 
 10. |          Dimethoate         0.419           0.320    Original | 
     |---------------------------------------------------------------| 
 11. |          Disulfoton         4.565           1.260    Original | 
 12. |            Ethoprop         0.240           0.060   Predicted | 
 13. |          Fenamiphos         0.650           0.040    Original | 
 14. |            Fenthion         1.569           0.330   Predicted | 
 15. |         Fosthiazate         0.396           0.070    Original | 
     |---------------------------------------------------------------| 
 16. |           Malathion         0.004           0.000    Original | 
 17. |       Methamidophos         1.097           1.000    Original | 
 18. |        Methidathion         0.266           0.320    Original | 
 19. |    Methyl-parathion         0.269           0.120    Original | 
 20. |           Mevinphos         0.539           0.760    Original | 
     |---------------------------------------------------------------| 
 21. |               Naled         0.033           0.080    Original | 
 22. |           Omethoate         0.775           0.930   Predicted | 
 23. |   Oxydemeton-methyl         0.574           0.860    Original | 
 24. |             Phorate         3.517           0.390    Original | 
 25. |           Phosalone         0.072           0.010    Original | 
     |---------------------------------------------------------------| 
 26. |             Phosmet         0.130           0.020    Original | 
 27. |       Phostebupirim         1.083           0.220   Predicted | 
 28. |   Pirimiphos-methyl         0.033           0.040    Original | 
 29. |          Profenofos         0.023           0.004   Predicted | 
 30. |            Terbufos         2.974           0.850    Original | 
     |---------------------------------------------------------------| 
 31. |   Tetrachlorvinphos         0.003           0.001    Original | 
 32. |            Tribufos         0.249           0.020    Original | 
 33. |         Trichlorfon         0.005           0.003    Original | 
     +---------------------------------------------------------------+ 
 
.          
. /*      Graphically show the result.    */ 
.         local ytitle: variable label potency_rbc 
 
.         local xtitle: variable label potency_brain 
 
.         graph drop _all 
 
.         twoway                                                                                          
>                                                                                  /// 
>                 (scatter potency_rbc potency_brain if rbc_group == 1, mcolor(blue))                     
>                  /// 
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>                 (scatter potency_rbc potency_brain if rbc_group == 0, mcolor(red))                      
>                          /// 
>                 (function y = x, range(0 2) lcolor(black))                                              
>                                                  /// 
>                 , legend(off) ytitle("`ytitle'") xtitle("`xtitle'")                                     
>                                  /// 
>                 note("Blue = RBC data from USEPA. Red = RBC data predicted.")                           
>                          /// 
>                 xsize(11.7) ysize(8.3) title("RBC vs. brain relative potency") 
 
.         graph export Graphs/rbc_vs_brain_relative_potency.pdf, replace 
(file Graphs/rbc_vs_brain_relative_potency.pdf written in PDF format) 
 
.         graph drop _all 
 
.          
. //      Export data. 
.         export excel chemical potency* rbc_group using brain_and_rbc_che_potency.xlsx,                  
>          /// 
>                 firstrow(varlabels) replace keepcellfmt 
 
file brain_and_rbc_che_potency.xlsx saved 
 
 
.          
. //      Clear data 
.         clear 
 
.          
. //      Stop logging 
.         log close 
      name:  <unnamed> 
       log:  C:\Users\au231481\Desktop\Potency EPA\predict_rbc_ache.log 
  log type:  text 
 closed on:   2 Aug 2019, 16:31:15 
---------------------------------------------------------------------------------------------------------  
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16 Appendix B: Table of assumed causal relationships between 
study variables 
The table on the following pages lists all the causal relationships between   that we believe (a priori) to be 
causally related to each other.  The table is provided to provide a better overview of the same relationships 
on the DAGs (directed acyclic graphs) in Appendix C. 
  Variable name in DAG Variable content 
Measured in 
PEXADU 
project? 
Causally influences these 
DAG variables 
Pa
rt
ici
pa
nt
 fa
ct
or
s 
Pe
rs
on
al
 ch
ar
ac
te
ris
tic
s 
AChE Acetylcholine esterase Measured FPG 
Age Age in years Measured 
AChE 
Basal_Metabolism 
Alcohol 
Biofuel_Burning 
Diet 
Physical_Activity 
Tobacco 
Organophosphate_Farming 
Other_Pesticides_Farming 
FPG 
Lung_Function 
BMI Body mass index Measured 
FPG 
Lung_Function 
Basal_Metabolism Basal metabolism Unmeasured BMI 
Height Height in centimeters Measured Lung_Function 
SES Socioeconomic status Measured 
Alcohol 
Diet 
Height 
Physical_Activity 
Tobacco 
Organophosphate_Farming 
Other_Pesticides_Farming 
Biofuel_Burning 
Sex Sex Measured 
AChE 
BMI 
Basal_Metabolism 
SES 
Alcohol 
Biofuel_Burning 
Diet 
Height 
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Tobacco 
Organophosphate_Farming 
Other_Pesticides_Farming 
FPG 
Lung_Function 
Be
ha
vi
or
 
Alcohol Alcohol consumption Measured 
AChE 
BMI 
FPG 
Biofuel_Burning Burning of biofuels Measured Biofuel_Smoke 
Diet Diet Measured 
BMI 
Organophosphate_Diet 
Other_Pesticide_Diet 
FPG 
Physical_Activity Physical activity level Measured 
Diet 
BMI 
FPG 
Tobacco Tobacco smoking Measured 
Diet 
FPG 
Lung_Function 
Ex
po
su
re
 
Biofuel_Smoke Exposure to biofuel smoke Unmeasured Lung_Function 
Organophosphate_Diet 
Exposure to 
organophosphates 
through diet 
Unmeasured Organophosphate_Total 
Organophosphate_Farming 
Exposure to 
organophosphates 
through farming 
Measured Organophosphate_Total 
Organophosphate_Total 
Total 
organophosphate 
exposure 
Unmeasured 
AChE 
FPG 
Lung_Function 
Other_Pesticide_Diet 
Exposure to other 
pesticides through 
diet 
Unmeasured Other_Pesticide_Total 
Other_Pesticide_Total Total exposure to other pesticides Unmeasured 
FPG 
Lung_Function 
Other_Pesticides_Farming 
Exposure to other 
pesticides through 
farming 
Measured Other_Pesticide_Total 
Ge
ne
s 
AChE_Genes Genes for AChE activity Unmeasured AChE 
Diabetes_Genes 
Genes for 
diabetes 
susceptibility 
Unmeasured FPG 
Height_Genes Genes for height Unmeasured Height 
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Lung_Function_Genes Genes for lung function Unmeasured Lung_Function 
Obesity_Genes Genes for obesity Unmeasured 
BMI 
Basal_Metabolism 
Pa
re
nt
al
 fa
ct
or
s t
ha
t c
an
 ca
us
al
ly
 a
ffe
ct
 p
ar
tic
ip
an
t 
Pe
rs
on
al
 ch
ar
ac
te
ris
tic
s 
Diabetes_(Parent) Diabetes in parent Measured 
SES 
Alcohol 
Diet 
Physical_Activity 
Tobacco 
Lung_Function_(Parent) Parent's lung function Measured 
Biofuel_Burning 
Tobacco 
SES_(Parent) 
Parent's 
socioeconomic 
status 
Unmeasured SES 
Be
ha
vi
or
 
Alcohol_(Parent) Parent's alcohol consumption Unmeasured Alcohol 
Biofuel_Burning_(Parent) Parent's burning of biofuels Unmeasured Biofuel_Burning 
Diet_(Parent) Parent's diet Unmeasured Diet 
Physical_Activity_(Parent) Parent's physical activity level Unmeasured Physical_Activity 
Tobacco_(Parent) Parent's tobacco smoking Unmeasured Tobacco 
Ge
ne
s 
AChE_Genes_(Parent) Parent's genes for AChE activity Unmeasured AChE_Genes 
Diabetes_Genes_(Parent) 
Parent's genes for 
diabetes 
susceptibility 
Unmeasured Diabetes_Genes 
Height_Genes_(Parent) Parent's genes for height Unmeasured Height_Genes 
Lung_Function_Genes_(Parent) Parent's genes for lung function Unmeasured Lung_Function_Genes 
Obesity_Genes_(Parent) Parent's genes for obesity Unmeasured Obesity_Genes 
 
FPG = fasting plasma glucose 
All causal relationship between variables listed as “Participant factors” are assumed to also exist for 
participants’ parents. E.g., a participant’s smoking is assumed to causally influence his/her lung function (as 
listed in the table), and his/her mother’s smoking is also assumed to influence the mother’s lung function 
(even though this is not listed in the table). 
The table indicates that we have data on the participants' parents' lung function. A previous diagnosis of 
asthma or COPD in the parents, reported by the participant, is used as a proxy for the parents' lung functions. 
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17 Appendix C: DAGs and causal effect reports from DAGitty 
The DAGs (Directed Acyclic graphs = causal diagrams) on the following pages were drawn using the DAGitty31 software, freely available from dagitty.net. Because of the 
complexity of the DAGs, they were analyzed automatically by DAGitty. Under each DAG, we have listed the output from the analysis. 
Legend for all DAGs: 
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17.1 Outcome = red blood cell acetylcholine esterase 
17.1.1 Exposure metric = self-reported use of organophosphate insecticides in farming 
 
Analysis protocol: Pesticide Exposure, Asthma and Diabetes in Uganda (PEXADU) 
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Causal effect identification 
Minimal sufficient adjustment sets for estimating the total effect of Organophosphate_Farming on AChE: 
Age, SES, Sex 
Testable implications 
The model implies the following conditional independences: 
Age ⊥ Sex 
Age ⊥ Diabetes_(Parent) 
Age ⊥ Height 
Age ⊥ Lung_Function_(Parent) 
Age ⊥ SES 
Sex ⊥ Diabetes_(Parent) 
Sex ⊥ Lung_Function_(Parent) 
AChE ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Alcohol ⊥ Height | SES, Sex 
Alcohol ⊥ Organophosphate_Farming | Age, SES, Sex 
Alcohol ⊥ Other_Pesticides_Farming | Age, SES, Sex 
BMI ⊥ Organophosphate_Farming | Age, SES, Sex 
BMI ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Biofuel_Burning ⊥ Organophosphate_Farming | Age, SES, Sex 
Biofuel_Burning ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Diabetes_(Parent) ⊥ Height | SES, Sex 
Diabetes_(Parent) ⊥ Organophosphate_Farming | SES, Sex 
Diabetes_(Parent) ⊥ Other_Pesticides_Farming | SES, Sex 
Diet ⊥ Organophosphate_Farming | Age, SES, Sex 
Diet ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Height ⊥ Organophosphate_Farming | SES, Sex 
Height ⊥ Other_Pesticides_Farming | SES, Sex 
Height ⊥ Physical_Activity | SES, Sex 
Lung_Function_(Parent) ⊥ Organophosphate_Farming | SES, Sex 
Lung_Function_(Parent) ⊥ Other_Pesticides_Farming | SES, Sex 
Organophosphate_Farming ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Organophosphate_Farming ⊥ Physical_Activity | Age, SES, Sex 
Organophosphate_Farming ⊥ Tobacco | Age, SES, Sex 
Other_Pesticides_Farming ⊥ Physical_Activity | Age, SES, Sex 
Other_Pesticides_Farming ⊥ Tobacco | Age, SES, Sex 
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17.2 Outcome = glycemic regulation, exemplified by fasting plasma glucose 
17.2.1 Exposure metric = self-reported use of organophosphate insecticides in farming 
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Causal effect identification 
Minimal sufficient adjustment sets for estimating the total effect of Organophosphate_Farming on FPG: 
Age, SES, Sex 
Testable implications 
The model implies the following conditional independences: 
Age ⊥ Sex 
Age ⊥ Diabetes_(Parent) 
Age ⊥ Height 
Age ⊥ Lung_Function_(Parent) 
Age ⊥ SES 
Sex ⊥ Diabetes_(Parent) 
Sex ⊥ Lung_Function_(Parent) 
AChE ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Alcohol ⊥ Height | SES, Sex 
Alcohol ⊥ Organophosphate_Farming | Age, SES, Sex 
Alcohol ⊥ Other_Pesticides_Farming | Age, SES, Sex 
BMI ⊥ Organophosphate_Farming | Age, SES, Sex 
BMI ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Biofuel_Burning ⊥ Organophosphate_Farming | Age, SES, Sex 
Biofuel_Burning ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Diabetes_(Parent) ⊥ Height | SES, Sex 
Diabetes_(Parent) ⊥ Organophosphate_Farming | SES, Sex 
Diabetes_(Parent) ⊥ Other_Pesticides_Farming | SES, Sex 
Diet ⊥ Organophosphate_Farming | Age, SES, Sex 
Diet ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Height ⊥ Organophosphate_Farming | SES, Sex 
Height ⊥ Other_Pesticides_Farming | SES, Sex 
Height ⊥ Physical_Activity | SES, Sex 
Lung_Function_(Parent) ⊥ Organophosphate_Farming | SES, Sex 
Lung_Function_(Parent) ⊥ Other_Pesticides_Farming | SES, Sex 
Organophosphate_Farming ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Organophosphate_Farming ⊥ Physical_Activity | Age, SES, Sex 
Organophosphate_Farming ⊥ Tobacco | Age, SES, Sex 
Other_Pesticides_Farming ⊥ Physical_Activity | Age, SES, Sex 
Other_Pesticides_Farming ⊥ Tobacco | Age, SES, Sex 
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17.2.2 Exposure metric = self-reported use of other classes of pesticides in farming 
 
Analysis protocol: Pesticide Exposure, Asthma and Diabetes in Uganda (PEXADU) 
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Causal effect identification 
Minimal sufficient adjustment sets for estimating the total effect of Other_Pesticides_Farming on FPG: 
Age, SES, Sex 
Testable implications 
The model implies the following conditional independences: 
Age ⊥ Sex 
Age ⊥ Diabetes_(Parent) 
Age ⊥ Height 
Age ⊥ Lung_Function_(Parent) 
Age ⊥ SES 
Sex ⊥ Diabetes_(Parent) 
Sex ⊥ Lung_Function_(Parent) 
AChE ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Alcohol ⊥ Height | SES, Sex 
Alcohol ⊥ Organophosphate_Farming | Age, SES, Sex 
Alcohol ⊥ Other_Pesticides_Farming | Age, SES, Sex 
BMI ⊥ Organophosphate_Farming | Age, SES, Sex 
BMI ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Biofuel_Burning ⊥ Organophosphate_Farming | Age, SES, Sex 
Biofuel_Burning ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Diabetes_(Parent) ⊥ Height | SES, Sex 
Diabetes_(Parent) ⊥ Organophosphate_Farming | SES, Sex 
Diabetes_(Parent) ⊥ Other_Pesticides_Farming | SES, Sex 
Diet ⊥ Organophosphate_Farming | Age, SES, Sex 
Diet ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Height ⊥ Organophosphate_Farming | SES, Sex 
Height ⊥ Other_Pesticides_Farming | SES, Sex 
Height ⊥ Physical_Activity | SES, Sex 
Lung_Function_(Parent) ⊥ Organophosphate_Farming | SES, Sex 
Lung_Function_(Parent) ⊥ Other_Pesticides_Farming | SES, Sex 
Organophosphate_Farming ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Organophosphate_Farming ⊥ Physical_Activity | Age, SES, Sex 
Organophosphate_Farming ⊥ Tobacco | Age, SES, Sex 
Other_Pesticides_Farming ⊥ Physical_Activity | Age, SES, Sex 
Other_Pesticides_Farming ⊥ Tobacco | Age, SES, Sex 
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17.2.3 Exposure metric = red blood cell acetylcholine esterase activity 
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Causal effect identification 
The total effect cannot be estimated by covariate adjustment. 
Testable implications 
The model implies the following conditional independences: 
Age ⊥ Sex 
Age ⊥ Diabetes_(Parent) 
Age ⊥ Height 
Age ⊥ Lung_Function_(Parent) 
Age ⊥ SES 
Sex ⊥ Diabetes_(Parent) 
Sex ⊥ Lung_Function_(Parent) 
AChE ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Alcohol ⊥ Height | SES, Sex 
Alcohol ⊥ Organophosphate_Farming | Age, SES, Sex 
Alcohol ⊥ Other_Pesticides_Farming | Age, SES, Sex 
BMI ⊥ Organophosphate_Farming | Age, SES, Sex 
BMI ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Biofuel_Burning ⊥ Organophosphate_Farming | Age, SES, Sex 
Biofuel_Burning ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Diabetes_(Parent) ⊥ Height | SES, Sex 
Diabetes_(Parent) ⊥ Organophosphate_Farming | SES, Sex 
Diabetes_(Parent) ⊥ Other_Pesticides_Farming | SES, Sex 
Diet ⊥ Organophosphate_Farming | Age, SES, Sex 
Diet ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Height ⊥ Organophosphate_Farming | SES, Sex 
Height ⊥ Other_Pesticides_Farming | SES, Sex 
Height ⊥ Physical_Activity | SES, Sex 
Lung_Function_(Parent) ⊥ Organophosphate_Farming | SES, Sex 
Lung_Function_(Parent) ⊥ Other_Pesticides_Farming | SES, Sex 
Organophosphate_Farming ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Organophosphate_Farming ⊥ Physical_Activity | Age, SES, Sex 
Organophosphate_Farming ⊥ Tobacco | Age, SES, Sex 
Other_Pesticides_Farming ⊥ Physical_Activity | Age, SES, Sex 
Other_Pesticides_Farming ⊥ Tobacco | Age, SES, Sex 
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17.3 Outcome = lung function 
17.3.1 Exposure metric = self-reported use of organophosphate insecticides in farming 
 
Analysis protocol: Pesticide Exposure, Asthma and Diabetes in Uganda (PEXADU) 
 
Page 74 of 78 
Causal effect identification 
Minimal sufficient adjustment sets for estimating the total effect of Organophosphate_Farming on Lung_Function: 
Age, SES, Sex 
Testable implications 
The model implies the following conditional independences: 
Age ⊥ Sex 
Age ⊥ Diabetes_(Parent) 
Age ⊥ Height 
Age ⊥ Lung_Function_(Parent) 
Age ⊥ SES 
Sex ⊥ Diabetes_(Parent) 
Sex ⊥ Lung_Function_(Parent) 
AChE ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Alcohol ⊥ Height | SES, Sex 
Alcohol ⊥ Organophosphate_Farming | Age, SES, Sex 
Alcohol ⊥ Other_Pesticides_Farming | Age, SES, Sex 
BMI ⊥ Organophosphate_Farming | Age, SES, Sex 
BMI ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Biofuel_Burning ⊥ Organophosphate_Farming | Age, SES, Sex 
Biofuel_Burning ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Diabetes_(Parent) ⊥ Height | SES, Sex 
Diabetes_(Parent) ⊥ Organophosphate_Farming | SES, Sex 
Diabetes_(Parent) ⊥ Other_Pesticides_Farming | SES, Sex 
Diet ⊥ Organophosphate_Farming | Age, SES, Sex 
Diet ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Height ⊥ Organophosphate_Farming | SES, Sex 
Height ⊥ Other_Pesticides_Farming | SES, Sex 
Height ⊥ Physical_Activity | SES, Sex 
Lung_Function_(Parent) ⊥ Organophosphate_Farming | SES, Sex 
Lung_Function_(Parent) ⊥ Other_Pesticides_Farming | SES, Sex 
Organophosphate_Farming ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Organophosphate_Farming ⊥ Physical_Activity | Age, SES, Sex 
Organophosphate_Farming ⊥ Tobacco | Age, SES, Sex 
Other_Pesticides_Farming ⊥ Physical_Activity | Age, SES, Sex 
Other_Pesticides_Farming ⊥ Tobacco | Age, SES, Sex 
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17.3.2 Exposure metric = self-reported use of other classes of pesticides in farming 
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Causal effect identification 
Minimal sufficient adjustment sets for estimating the total effect of Other_Pesticides_Farming on Lung_Function: 
Age, SES, Sex 
Testable implications 
The model implies the following conditional independences: 
Age ⊥ Sex 
Age ⊥ Diabetes_(Parent) 
Age ⊥ Height 
Age ⊥ Lung_Function_(Parent) 
Age ⊥ SES 
Sex ⊥ Diabetes_(Parent) 
Sex ⊥ Lung_Function_(Parent) 
AChE ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Alcohol ⊥ Height | SES, Sex 
Alcohol ⊥ Organophosphate_Farming | Age, SES, Sex 
Alcohol ⊥ Other_Pesticides_Farming | Age, SES, Sex 
BMI ⊥ Organophosphate_Farming | Age, SES, Sex 
BMI ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Biofuel_Burning ⊥ Organophosphate_Farming | Age, SES, Sex 
Biofuel_Burning ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Diabetes_(Parent) ⊥ Height | SES, Sex 
Diabetes_(Parent) ⊥ Organophosphate_Farming | SES, Sex 
Diabetes_(Parent) ⊥ Other_Pesticides_Farming | SES, Sex 
Diet ⊥ Organophosphate_Farming | Age, SES, Sex 
Diet ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Height ⊥ Organophosphate_Farming | SES, Sex 
Height ⊥ Other_Pesticides_Farming | SES, Sex 
Height ⊥ Physical_Activity | SES, Sex 
Lung_Function_(Parent) ⊥ Organophosphate_Farming | SES, Sex 
Lung_Function_(Parent) ⊥ Other_Pesticides_Farming | SES, Sex 
Organophosphate_Farming ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Organophosphate_Farming ⊥ Physical_Activity | Age, SES, Sex 
Organophosphate_Farming ⊥ Tobacco | Age, SES, Sex 
Other_Pesticides_Farming ⊥ Physical_Activity | Age, SES, Sex 
Other_Pesticides_Farming ⊥ Tobacco | Age, SES, Sex 
 
Analysis protocol: Pesticide Exposure, Asthma and Diabetes in Uganda (PEXADU) 
 
Page 77 of 78 
17.4 Exposure metric = red blood cell acetylcholine esterase activity 
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Causal effect identification 
The total effect cannot be estimated by covariate adjustment. 
Testable implications 
The model implies the following conditional independences: 
Age ⊥ Sex 
Age ⊥ Diabetes_(Parent) 
Age ⊥ Height 
Age ⊥ Lung_Function_(Parent) 
Age ⊥ SES 
Sex ⊥ Diabetes_(Parent) 
Sex ⊥ Lung_Function_(Parent) 
AChE ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Alcohol ⊥ Height | SES, Sex 
Alcohol ⊥ Organophosphate_Farming | Age, SES, Sex 
Alcohol ⊥ Other_Pesticides_Farming | Age, SES, Sex 
BMI ⊥ Organophosphate_Farming | Age, SES, Sex 
BMI ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Biofuel_Burning ⊥ Organophosphate_Farming | Age, SES, Sex 
Biofuel_Burning ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Diabetes_(Parent) ⊥ Height | SES, Sex 
Diabetes_(Parent) ⊥ Organophosphate_Farming | SES, Sex 
Diabetes_(Parent) ⊥ Other_Pesticides_Farming | SES, Sex 
Diet ⊥ Organophosphate_Farming | Age, SES, Sex 
Diet ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Height ⊥ Organophosphate_Farming | SES, Sex 
Height ⊥ Other_Pesticides_Farming | SES, Sex 
Height ⊥ Physical_Activity | SES, Sex 
Lung_Function_(Parent) ⊥ Organophosphate_Farming | SES, Sex 
Lung_Function_(Parent) ⊥ Other_Pesticides_Farming | SES, Sex 
Organophosphate_Farming ⊥ Other_Pesticides_Farming | Age, SES, Sex 
Organophosphate_Farming ⊥ Physical_Activity | Age, SES, Sex 
Organophosphate_Farming ⊥ Tobacco | Age, SES, Sex 
Other_Pesticides_Farming ⊥ Physical_Activity | Age, SES, Sex 
Other_Pesticides_Farming ⊥ Tobacco | Age, SES, Sex 
 
